Intellectual Disability, Autosomal Recessive 43

🏷

Classifications

Harrison's Part

🔗

Mappings

MONDO

MONDO:0014354 intellectual disability, autosomal recessive 43

Primary MONDO identifier for this entry. MONDO:0014354 is a leaf term with no descendants and a single causal-gene assertion (RO:0004003 HGNC:29174, WASHC4), which is exactly the entity this file curates.

MONDO:0019502 autosomal recessive non-syndromic intellectual disability DisMech

The asserted MONDO parent (rdfs:subClassOf) and the MONDO term of the class-level entry Autosomal_Recessive_Non-Syndromic_Intellectual_Disability. Recorded as broadMatch, not exactMatch: the class covers the whole MRT series. Note also that the "non-syndromic" element of that parent label is contradicted by the post-2011 WASHC4 literature; see notes.

👪

Inheritance

1

Autosomal recessive HP:0000007

Two damaging WASHC4 alleles are required. The founding family was consanguineous and the affected members homozygous; later families carry compound heterozygous variants inherited one from each parent, and one further sibship is homozygous. No heterozygous carrier has been reported as affected.

Autosomal recessive inheritance

Show evidence (2 references)

PMID:31953988 SUPPORT Human Clinical

"Here we describe three additional patients (from two unrelated families) with syndromic ID due to compound heterozygous KIAA1033 variants ascertained by exome sequencing (ES)."

Biallelic (compound heterozygous) variants inherited one from each parent in two unrelated families is the recessive transmission pattern.

PMID:21498477 SUPPORT Human Clinical

"In a large consanguineous family with autosomal recessive intellectual disability (ARID), we have combined homozygosity mapping, targeted exon enrichment and high-throughput sequencing to identify the underlying gene defect."

The founding pedigree is consanguineous and was mapped by homozygosity mapping, which is only informative for a recessive, identical-by-descent locus.

?

Discussions and Knowledge Gaps

3

Is MRT43 a non-syndromic intellectual disability, as its MONDO placement and its founding report say, or a syndromic one, as every subsequent report says?

CONTROVERSY OPEN mrt43_nonsyndromic_label_unstable

Attached to

phenotypes#Dysmorphic Facial Features phenotypes#Skeletal Muscle Involvement

MONDO:0014354 is a child of MONDO:0019502, autosomal recessive NON-syndromic intellectual disability, and the 2011 title says "non-syndromic". The 2020 paper's own title says "syndromic intellectual disability", the 2022 title says "a syndromic phenotype", and between them they report dysmorphism, skeletal anomalies, subependymal nodular heterotopia, hearing loss, an absent internal carotid artery and skeletal muscle involvement. This entry curates the phenotype the later reports describe while keeping the MONDO binding, because the identifier is what the community indexes against; the disagreement is recorded here rather than resolved by silently recategorising the disorder. This is the same instability the class-level entry Autosomal_Recessive_Non-Syndromic_Intellectual_Disability already flags for NSUN2, MAN1B1 and ADAT3 - MRT43 is another instance of it, not a new phenomenon.

Show evidence (1 reference)

PMID:31953988 SUPPORT Human Clinical

"We conclude that KIAA1033 is responsible for a heterogeneous ARID phenotype, and additional description will be needed to refine the clinical phenotype."

The authors themselves decline to settle the phenotype, which is the unresolved state this discussion records.

Is MRT43 a static developmental encephalopathy, or does the endo-lysosomal defect drive a slowly progressive neurodegenerative process in patients?

KNOWLEDGE GAP OPEN mrt43_static_or_degenerative

Attached to

pathophysiology#Neuronal Endo-Lysosomal Dysfunction phenotypes#Movement Impairment

The MRT series is conventionally treated as static, and developmental regression is taken to argue against the diagnosis. The knock-in mouse says otherwise for this gene: lipofuscin accumulation, progressive caspase-3 activation, and motor decline that worsens between adolescence and adulthood. The human evidence is a retrospective chart review that found movement deficits, not a longitudinal study that found progression. No patient has been followed prospectively, and no human neuropathology exists. Resolving this changes surveillance - whether these patients need serial motor assessment - and it changes whether MRT43 should be described as a neurodevelopmental or a neurodegenerative disorder.

Show evidence (1 reference)

PMID:33749590 SUPPORT Model Organism

"Cellular and histological analyses confirm that SWIPP1019R results in endo-lysosomal disruption and uncover indicators of neurodegeneration."

The neurodegenerative indicators that make the question live are established in the mouse; the gap is that they have not been sought in patients.

Is there any evidence bearing on management of MRT43, beyond generic intellectual-disability supportive care?

KNOWLEDGE GAP OPEN mrt43_no_therapeutic_evidence

Attached to

treatments#

No treatment study, management guideline, natural-history study, clinical trial or GeneReviews chapter exists for WASHC4-related disease. The two treatment entries here are ordinary supportive practice and carry no evidence for that reason, which is recorded explicitly rather than papered over with a quotation from an unrelated intellectual-disability paper. With fewer than fifteen reported patients this is a consequence of cohort size, not of neglect, and the first thing needed is a natural-history description rather than an intervention.

Show evidence (1 reference)

PMID:31953988 SUPPORT Human Clinical

"Since then, no other cases of KIAA1033 variants have been reported."

Supports the cohort-size explanation: nine years after the founding report the total published series was still one family.

⚙

Pathophysiology

7

Biallelic WASHC4 Loss of Function

Two damaging WASHC4 alleles - homozygous missense p.Pro1019Arg in the founding pedigree, truncating and missense compound heterozygous pairs in later families - reduce the amount of functional SWIP protein available to the WASH complex.

WASHC4 hgnc:29174

Genetic context WASHC4 hgnc:29174 variant_origin: GERMLINE zygosity: HOMOZYGOUS functional_impact_category: LOSS_OF_FUNCTION

The founding allele is homozygous by descent in a consanguineous pedigree; subsequent families are compound heterozygous. The functionally studied missense allele lowers SWIP protein level rather than creating a new activity, which is why it is classified as loss of function.

Downstream

WASH Complex Destabilization Reduced SWIP levels destabilise the assembled pentamer.

Show evidence (1 reference)

PMID:21498477 SUPPORT Human Clinical

"In a large consanguineous family with autosomal recessive intellectual disability (ARID), we have combined homozygosity mapping, targeted exon enrichment and high-throughput sequencing to identify the underlying gene defect."

Establishes that the initiating lesion is a biallelic autosomal locus identified by autozygosity mapping in an affected pedigree.

WASH Complex Destabilization

SWIP/WASHC4 is one of five subunits of a roughly 500 kDa core complex that also contains WASH, Strumpellin (WASHC5), FAM21 (WASHC2) and CCDC53 (WASHC3). Loss of SWIP does not merely remove one subunit: the assembled complex falls apart, so the WASH nucleation-promoting factor is lost from its site of action together with the subunits that anchor and regulate it.

WASH complex GO:0071203

endosome GO:0005768

Animal models

SWIP P1019R knock-in mouse Mouse recapitulates Spatial proteomics of mutant mouse brain shows the same complex destabilisation demonstrated for the patient allele in cells.

Downstream

Loss of SWIP-Mediated Endosomal Membrane Anchoring SWIP is itself one of the two membrane anchors of the complex, so losing it removes an attachment point as well as a structural subunit.

Loss of Endosomal Branched-Actin Nucleation The complex exists to present the WASH nucleation-promoting factor to Arp2/3 at the endosome; a destabilised complex cannot do so.

Show evidence (2 references)

PMID:20498093 SUPPORT In Vitro

"Here we show that WASH functions in cells within a 500 kDa core complex containing Strumpellin, FAM21, KIAA1033 (SWIP), and CCDC53."

Defines the complex whose destabilisation this node describes and places KIAA1033/SWIP - the MRT43 gene product - inside it.

PMID:33749590 SUPPORT Model Organism

"Quantitative spatial proteomics analysis of SWIPP1019R mouse brain reveals that this mutation destabilizes the WASH complex and uncovers significant perturbations in both endosomal and lysosomal pathways."

Confirms in brain tissue of an animal carrying the human patient allele that the complex is destabilised, not just in cultured cells.

Loss of SWIP-Mediated Endosomal Membrane Anchoring

The textbook route by which the WASH complex reaches the endosomal membrane is the FAM21-VPS35 interaction with retromer. SWIP provides a second, retromer-INDEPENDENT anchor, binding phosphoinositides directly, with PI(3,5)P2 the species that matters for endosomal binding. Loss of SWIP therefore removes an anchor that retromer cannot substitute for. This is a deliberate qualification of the common shorthand that WASH acts only downstream of retromer.

phosphatidylinositol-3,5-bisphosphate binding GO:0080025

endosome GO:0005768

Downstream

Loss of Endosomal Branched-Actin Nucleation A complex that cannot be held at the endosomal surface cannot nucleate actin there.

Show evidence (2 references)

PMID:36995008 SUPPORT In Vitro

"The retromer-independent membrane anchor is directly mediated by the subunit SWIP."

Directly attributes a membrane-anchoring function to the MRT43 gene product itself, which is what makes its loss more than the loss of a structural filler subunit.

PMID:36995008 SUPPORT In Vitro

"It is generally accepted that WASH complex attaches to the endosomal membrane via the interaction of its subunit FAM21 with the retromer subunit VPS35."

Records the retromer-dependent route this node is contrasted with, so the qualification in the node description is attributable rather than editorial.

Loss of Endosomal Branched-Actin Nucleation

The WASH complex's output is activation of Arp2/3 on the endosomal surface, producing localised branched-actin patches. Without it, the force that shapes and pinches the sorting tubules leaving the endosome is not generated.

Arp2/3 complex-mediated actin nucleation GO:0034314 ↓ DECREASED actin filament polymerization GO:0030041 ↓ DECREASED

Arp2/3 complex binding GO:0071933

early endosome GO:0005769

Downstream

Failed Endosomal Cargo Sorting and Tubule Fission

Show evidence (1 reference)

PMID:34599609 SUPPORT In Vitro

"The protein encoded by WASHC4 is part of the Wiskott-Aldrich syndrome protein and SCAR homolog family, co-localizes with actin in cells, and promotes Arp2/3-dependent actin polymerization in vitro."

Attributes Arp2/3-dependent actin polymerisation to the WASHC4 gene product specifically, so its loss is expected to reduce that activity.

Failed Endosomal Cargo Sorting and Tubule Fission

Cargo that should leave the sorting endosome in a scission-competent tubule - for recycling to the surface or retrograde delivery to the Golgi - is not retrieved efficiently. The endosomal and lysosomal compartments enlarge and substrate accumulates.

endosomal transport GO:0016197 ↓ DECREASED endocytic recycling GO:0032456 ↓ DECREASED retrograde transport, endosome to Golgi GO:0042147 ↓ DECREASED endosome organization GO:0007032

Downstream

Neuronal Endo-Lysosomal Dysfunction

Impaired Autophagic Protein Clearance in Striated Muscle The muscle arm is supported by zebrafish knockdown and by patient muscle and fibroblast proteomics, not by a demonstrated step from endosomal sorting to autophagic flux in human muscle.

Show evidence (1 reference)

PMID:33749590 SUPPORT Model Organism

"Destabilization of the WASH complex leads to enlarged endosomes and lysosomes, with increased substrate accumulation at the lysosome."

Describes the morphological and cargo-handling consequence at the compartment level that this node names.

Neuronal Endo-Lysosomal Dysfunction

In brain the sorting failure presents as a disturbed endo-lysosomal axis: enlarged endosomes and lysosomes, raised lysosomal enzyme levels, ER stress, accumulation of lipofuscin-like residual bodies, and progressive activation of apoptotic markers. The pattern is degenerative rather than purely developmental, which matters because MRT-series entities are usually treated as static encephalopathies.

neuron CL:0000540

lysosome organization GO:0007040

lysosome GO:0005764

brain UBERON:0000955

Animal models

SWIP P1019R knock-in mouse Mouse recapitulates Enlarged endosomes and lysosomes, lipofuscin accumulation and progressive caspase-3 activation in mutant brain.

Downstream

Intellectual Disability The cognitive phenotype is attributed to the endo-lysosomal defect, but the intervening circuit-level step is not established.

Movement Impairment

Show evidence (1 reference)

PMID:33749590 SUPPORT Model Organism

"Cellular analyses confirm a significant impact on neuronal endo-lysosomal trafficking in vitro and in vivo, with evidence of lipofuscin accumulation and progressive apoptosis activation, molecular phenotypes that are indicative of neurodegenerative pathology."

Names the specific cellular findings - lipofuscin accumulation, apoptosis activation - that this node asserts.

Impaired Autophagic Protein Clearance in Striated Muscle

Outside the nervous system, WASHC4 loss disturbs protein clearance in striated muscle. Zebrafish washc4 inactivation causes ER stress and interferes with autophagy without impairing the ubiquitin-proteasome system, and proteins relevant to muscle function are dysregulated in a patient muscle biopsy and in patient fibroblasts.

muscle cell CL:0000187

autophagy GO:0006914 ↓ DECREASED

skeletal muscle tissue UBERON:0001134

Experimental models

WASHC4-deficient patient dermal fibroblasts PRIMARY CELL CULTURE Proteomic profiling of the patient's fibroblasts identified dysregulation of proteins relevant to the neuromuscular axis, which is what directed the subsequent muscle-biopsy analysis.

Animal models

Zebrafish washc4 loss-of-function Zebrafish recapitulates Washc4 inactivation impairs cardiac and skeletal muscle function and structure and interferes with autophagy, with ER stress but an intact ubiquitin-proteasome system.

Downstream

Skeletal Muscle Involvement

Show evidence (1 reference)

PMID:30010465 SUPPORT Model Organism

"Notably, loss of Vcp resulted in compromised protein degradation via the proteasome and the macroautophagy/autophagy machinery, whereas Washc4 deficiency did not affect the function of the ubiquitin-proteasome system (UPS) but caused ER stress and interfered with autophagy function in vivo."

Specifies the arm of proteostasis that Washc4 loss affects in vivo - autophagy and ER stress, not the proteasome - which is the claim this node makes.

⬡

Pathograph

Use the checkboxes to hide or show graph categories. Hover nodes for evidence and cross-linked metadata.

●

Phenotypes

16

Cardiovascular 1

Congenital Absence of the Internal Carotid Artery VERY_RARE Abnormal internal carotid artery morphology HP:3000062

Bound to HP:3000062 Abnormal internal carotid artery morphology, which is a parent term. HPO has no term for agenesis or aplasia of the internal carotid artery: the nearest candidates are HP:0005290 Internal carotid artery hypoplasia, which asserts a hypoplastic rather than an absent vessel, and HP:0031604 Agenesis of the carotid canal, which is the bony canal rather than the artery. Neither is what the source reports, so the accurate parent is bound and the specific finding is carried in preferred_term.

Show evidence (1 reference)

PMID:31953988 SUPPORT Human Clinical

"In addition, the younger sibling had a congenital absence of the right internal carotid and bilateral sensorineural hearing loss."

Single-patient report of congenital absence of the right internal carotid artery in a WASHC4-biallelic individual. This is the vascular half of the same sentence whose auditory half supports the hearing-loss phenotype.

Ear 1

Sensorineural Hearing Loss VERY_RARE Sensorineural hearing impairment HP:0000407

Show evidence (1 reference)

PMID:31953988 SUPPORT Human Clinical

"In addition, the younger sibling had a congenital absence of the right internal carotid and bilateral sensorineural hearing loss."

Single-patient report of bilateral sensorineural hearing loss in a WASHC4-biallelic individual.

Head and Neck 3

Dysmorphic Facial Features Abnormal facial shape HP:0001999

Show evidence (2 references)

PMID:31953988 SUPPORT Human Clinical

"Both had learning disabilities, macrocephaly, dysmorphic features, skeletal anomalies, and subependymal heterotopic nodules."

Reports dysmorphic features in two affected sisters.

PMID:34599609 SUPPORT Human Clinical

"Recessive variants in WASHC4 are linked to intellectual disability complicated by poor language skills, short stature, and dysmorphic features."

Independent confirmation that dysmorphism belongs to the WASHC4 phenotype.

Macrocephaly OCCASIONAL HP:0000256

Show evidence (1 reference)

PMID:31953988 SUPPORT Human Clinical

"Both had learning disabilities, macrocephaly, dysmorphic features, skeletal anomalies, and subependymal heterotopic nodules."

Directly reports macrocephaly in two affected siblings.

Microcephaly OCCASIONAL HP:0000252

Show evidence (1 reference)

PMID:31953988 SUPPORT Human Clinical

"This patient presented with mild ID, short stature, and microcephaly."

Directly reports microcephaly in one patient.

Musculoskeletal 2

Skeletal Anomalies OCCASIONAL Abnormality of the skeletal system HP:0000924

Show evidence (1 reference)

PMID:31953988 SUPPORT Human Clinical

"Both had learning disabilities, macrocephaly, dysmorphic features, skeletal anomalies, and subependymal heterotopic nodules."

Reports skeletal anomalies as part of the syndromic presentation.

Skeletal Muscle Involvement OCCASIONAL Myopathy HP:0003198

Bound to HP:0003198 Myopathy, which is broader than what was shown. The evidence is biopsy immunostaining and proteomics, not a clinical myopathy syndrome with weakness, raised creatine kinase and myopathic EMG in a series; the preferred_term is kept at the weaker "Skeletal muscle involvement" for that reason.

Show evidence (2 references)

PMID:34599609 SUPPORT Human Clinical

"The proteomic analysis confirmed key molecular players in vitro and highlighted, for the first time, the involvement of skeletal muscle in patients."

States that skeletal muscle involvement was demonstrated in patients.

PMID:34599609 SUPPORT Human Clinical

"However, skeletal muscle involvement has not been reported so far in patients, and precise biochemical studies allowing a deeper understanding of the molecular etiology of the disease are still lacking."

The same paper's statement of the prior state of knowledge, which is why this phenotype is marked OCCASIONAL and dated to 2022 rather than treated as a long-established feature.

Nervous System 8

Intellectual Disability VERY_FREQUENT HP:0001249

Sequelae: Delayed Speech and Language Development

Show evidence (3 references)

PMID:21498477 SUPPORT Human Clinical

"In a large consanguineous family with autosomal recessive intellectual disability (ARID), we have combined homozygosity mapping, targeted exon enrichment and high-throughput sequencing to identify the underlying gene defect."

Intellectual disability is the ascertaining phenotype of the founding pedigree.

PMID:31953988 SUPPORT Human Clinical

"In 2011, KIAA1033/WASHC4 was associated with autosomal recessive intellectual disability (ARID) in a large consanguineous family comprising seven affected individuals with moderate ID and short stature."

Records the severity band in the largest reported family.

PMID:31953988 SUPPORT Human Clinical

"This patient presented with mild ID, short stature, and microcephaly."

Documents the mild end of the severity range, which is why no severity-specific HPO term is bound.

Delayed Speech and Language Development HP:0000750

Show evidence (1 reference)

PMID:34599609 SUPPORT Human Clinical

"Recessive variants in WASHC4 are linked to intellectual disability complicated by poor language skills, short stature, and dysmorphic features."

Names poor language skills as part of the established WASHC4 phenotype.

Subependymal Nodular Heterotopia OCCASIONAL Periventricular nodular heterotopia HP:0032388

Show evidence (1 reference)

PMID:31953988 SUPPORT Human Clinical

"Both had learning disabilities, macrocephaly, dysmorphic features, skeletal anomalies, and subependymal heterotopic nodules."

Directly reports the neuronal migration abnormality in two siblings.

Movement Impairment Abnormality of movement HP:0100022

Sequelae: Dysmetria Dysdiadochokinesis Dysarthria Delayed Fine Motor Development

Show evidence (2 references)

PMID:33749590 SUPPORT Human Clinical

"A retrospective analysis of SWIPP1019R patients reveals similar movement deficits in humans."

The human observation for this phenotype; the study is a mouse paper, but this specific sentence reports a retrospective analysis of the patients.

PMID:33749590 SUPPORT INDIRECT Model Organism

"Interestingly, while gait parameters of the mice were largely indistinguishable across genotypes at adolescence, a striking difference was seen when the same mice were aged to adulthood"

Supports the progressive character of the phenotype - gait is normal in adolescent mutants and abnormal in the same animals as adults - but in the knock-in mouse rather than in patients, whose human data are a retrospective chart review.

Dysmetria HP:0001310

Show evidence (1 reference)

PMID:33749590 SUPPORT Human Clinical

"with notable fine motor difficulties, dysmetria, dysdiadochokinesia, and mild dysarthria on clinical exam"

The clinical-examination sentence names dysmetria among the motor signs found on re-evaluation of the human patients.

Dysdiadochokinesis HP:0002075

Show evidence (1 reference)

PMID:33749590 SUPPORT Human Clinical

"with notable fine motor difficulties, dysmetria, dysdiadochokinesia, and mild dysarthria on clinical exam"

The same sentence names dysdiadochokinesia among the examination findings.

Dysarthria HP:0001260

Show evidence (1 reference)

PMID:33749590 SUPPORT Human Clinical

"with notable fine motor difficulties, dysmetria, dysdiadochokinesia, and mild dysarthria on clinical exam"

The same sentence reports mild dysarthria on clinical exam.

Delayed Fine Motor Development HP:0010862

Show evidence (1 reference)

PMID:33749590 SUPPORT Human Clinical

"with notable fine motor difficulties, dysmetria, dysdiadochokinesia, and mild dysarthria on clinical exam"

The same sentence reports notable fine motor difficulties. The HPO term is developmental in framing while the source describes examination findings at a mean age of 10.4 years, so the binding is the closest available rather than an exact restatement.

Growth 1

Short Stature FREQUENT HP:0004322

Show evidence (2 references)

PMID:31953988 SUPPORT Human Clinical

"In 2011, KIAA1033/WASHC4 was associated with autosomal recessive intellectual disability (ARID) in a large consanguineous family comprising seven affected individuals with moderate ID and short stature."

Short stature is reported together with the intellectual disability in the founding family.

PMID:34599609 SUPPORT Human Clinical

"Recessive variants in WASHC4 are linked to intellectual disability complicated by poor language skills, short stature, and dysmorphic features."

Confirms short stature as an established feature of the gene-disease relationship, independent of the founding report.

🧬

Genetic Associations

1

WASHC4

Gene: WASHC4 hgnc:29174 relationship_type: CAUSATIVE variant_origin: GERMLINE

Show evidence (2 references)

PMID:21498477 SUPPORT Human Clinical

"a member of the recently discovered WASH complex, which is involved in actin polymerization and multiple endosomal transport processes."

Identifies the gene the founding study implicated (SWIP/WASHC4) and the complex and cellular process it belongs to.

PMID:34599609 SUPPORT Human Clinical

"Recessive variants in WASHC4 are linked to intellectual disability complicated by poor language skills, short stature, and dysmorphic features."

States the gene-disease relationship in its current, post-2011 form.

Variants (4)

c.3056C>G p.(Pro1019Arg)

missense

The founding allele, homozygous in the consanguineous Omani pedigree. It is the only WASHC4 disease allele that has been functionally characterised and modelled in an animal; it destabilises the WASH complex rather than abolishing the protein.

Show evidence (1 reference)

PMID:33749590 SUPPORT Human Clinical

"In particular, an autosomal recessive mutation inWASHC4(c.3056C>G; p.Pro1019Arg) was identified in a cohort of children with non-syndromic intellectual disability"

Names the nucleotide and protein change of the founding allele and the cohort it was found in. The run-together spacing is the cached text's own, produced by the loss of italic markup around the gene symbol.

p.(Gln442*) / p.(Asp1048Gly)

compound heterozygous stop-gain and missense

Compound heterozygous pair in the two sisters of the 2020 report, one allele inherited from each parent.

Show evidence (1 reference)

PMID:31953988 SUPPORT Human Clinical

"Two sisters, aged 4 and 5.5 years, had a stop-gain and a missense variants, each inherited from one parent (p.(Gln442*) and p.(Asp1048Gly))."

Names both alleles and states that each was inherited from one parent.

p.(Lys1079Arg) / p.(His503Arg)

compound heterozygous missense

Compound heterozygous missense pair in the third patient of the 2020 report, a 34-year-old with mild intellectual disability, short stature and microcephaly.

Show evidence (1 reference)

PMID:31953988 SUPPORT Human Clinical

"The third patient was aged 34 years and had two missense variants, one inherited from each parent (p.(Lys1079Arg) and p.(His503Arg))."

Names both alleles and the biparental inheritance in the third patient.

Unnamed homozygous WASHC4 variant (2022 sibship)

A homozygous WASHC4 variant in the two siblings reported in 2022. The abstract states that the variant is homozygous but does not give its nucleotide or protein change, and the full text is not in the reference cache, so no allele designation is asserted here.

Show evidence (1 reference)

PMID:34599609 SUPPORT Human Clinical

"Here, we report two siblings with a homozygous WASHC4 variant expanding the clinical spectrum of the disease and provide a phenotypical comparison with cases reported in the literature."

Establishes that this sibship is homozygous for a WASHC4 variant, without naming the allele.

💊

Medical Actions

5

Developmental and Educational Intervention

Action: developmental and educational support for intellectual disability Ontology label: Rehabilitation NCIT:C15315

Platform: Behavioral / lifestyle

Special education and developmental support for the intellectual disability. This is generic intellectual-disability management applied to MRT43; no study has assessed any intervention in WASHC4-related disease, and none is cited here because none exists.

Target Phenotypes: Intellectual disability HP:0001249

Speech and Language Therapy

Action: speech and language therapy Ontology label: Speech Language Therapy NCIT:C159273

Platform: Behavioral / lifestyle

Speech and language intervention for the delayed language development and poor expressive speech, which are among the most consistently reported features. As with the other supportive measures, no WASHC4-specific study has assessed it.

Target Phenotypes: Delayed speech and language development HP:0000750

Physical Therapy

Action: physical therapy Ontology label: Physical Therapy NCIT:C15302

Platform: Behavioral / lifestyle

Physical therapy for the motor signs - fine motor difficulty, dysmetria, dysdiadochokinesis - and for the skeletal and muscle involvement. Ordinary supportive practice; no WASHC4-specific study has assessed it.

Target Phenotypes: Movement abnormality HP:0100022 Myopathy HP:0003198

Occupational Therapy

Action: occupational therapy Ontology label: Occupational Therapy NCIT:C121351

Platform: Behavioral / lifestyle

Occupational therapy for the fine motor difficulty and for adaptive and daily-living skills. Ordinary supportive practice; no WASHC4-specific study has assessed it.

Target Phenotypes: Delayed fine motor development HP:0010862

Audiological Management

Action: Rehabilitation NCIT:C15315

Platform: Behavioral / lifestyle

Assessment and amplification for the bilateral sensorineural hearing loss reported in one patient. Applies only to the patient subset with hearing loss.

Target Phenotypes: Bilateral sensorineural hearing loss HP:0000407

🔬

Diagnosis

4

Exome sequencing

All reported families were solved by sequencing. The founding pedigree was identified by homozygosity mapping followed by targeted exon enrichment and high-throughput sequencing; the later families were ascertained by diagnostic exome sequencing. There is no biochemical marker and no functional assay in clinical use, so molecular testing is the diagnosis.

Whole exome sequencing NCIT:C101295

Markers: Biallelic pathogenic or likely pathogenic WASHC4 (KIAA1033) variants.

Show evidence (2 references)

PMID:31953988 SUPPORT Human Clinical

"Here we describe three additional patients (from two unrelated families) with syndromic ID due to compound heterozygous KIAA1033 variants ascertained by exome sequencing (ES)."

Exome sequencing is named as the method by which these diagnoses were made.

PMID:21498477 SUPPORT Human Clinical

"In a large consanguineous family with autosomal recessive intellectual disability (ARID), we have combined homozygosity mapping, targeted exon enrichment and high-throughput sequencing to identify the underlying gene defect."

Records the sequencing-based route to the founding diagnosis.

Brain MRI

Neuroimaging is not diagnostic of MRT43 but is what discloses the subependymal heterotopic nodules described in two affected sisters, a structural finding that would not be suspected clinically.

Magnetic resonance imaging NCIT:C16809

The cited abstract does not state the imaging modality. MRI is the modality in which subependymal nodular heterotopia is identified in practice, but that is inference, not a sourced statement about these patients.

Show evidence (1 reference)

PMID:31953988 SUPPORT INDIRECT Human Clinical

"Both had learning disabilities, macrocephaly, dysmorphic features, skeletal anomalies, and subependymal heterotopic nodules."

The abstract reports the imaging finding without naming the modality; subependymal heterotopic nodules are a neuroimaging diagnosis, so the inference that brain imaging was performed is one step removed from what the quote states. Graded INDIRECT for that reason.

Genetic counseling

Confirmation of biallelic WASHC4 variants establishes a 25% sibling recurrence risk and identifies both parents as carriers.

Genetic counseling NCIT:C15240

Show evidence (1 reference)

PMID:31953988 SUPPORT INDIRECT Human Clinical

"Here we describe three additional patients (from two unrelated families) with syndromic ID due to compound heterozygous KIAA1033 variants ascertained by exome sequencing (ES)."

Establishes carrier status of both parents in each family, which is the fact that recurrence-risk counselling rests on. The 25% figure itself is the standard recessive expectation and is not asserted by the quote.

Audiological assessment

Formal hearing assessment, prompted by the bilateral sensorineural hearing loss reported in one of the 2020 patients. Applies to case finding for that feature; it is not a test for MRT43 itself, which is diagnosed molecularly.

audiological assessment

No NCIT clinical-action term for audiological assessment is reachable from NCIT:C25218, so this entry carries a free-text preferred_term only, matching the treatment entry in Congenital_Heart_Defects_and_Skeletal_Malformations_Syndrome. NCIT:C85857 Evoked Response Audiometry is reachable and would validate, but the source does not say which test was performed, and binding a specific audiometric modality the report never names would manufacture specificity the evidence does not carry.

Show evidence (1 reference)

PMID:31953988 SUPPORT INDIRECT Human Clinical

"In addition, the younger sibling had a congenital absence of the right internal carotid and bilateral sensorineural hearing loss."

Establishes the finding that makes audiological assessment relevant. The source reports the hearing loss but does not describe the assessment pathway, so this is indirect support for the diagnostic entry rather than a statement that audiology is part of a workup.

📊

Prevalence

1

Worldwide, published cases

Cases In Literature Ultra Rare

Fewer than fifteen affected individuals from four families are described in the primary literature as of 2026: seven in the 2011 Omani consanguineous pedigree, three from two unrelated families in 2020, and two sisters in 2022. No population frequency estimate, birth prevalence, or carrier frequency has been published, and no Orphanet epidemiology record was available, so no numeric rate is asserted here.

Show evidence (2 references)

PMID:31953988 SUPPORT Human Clinical

"Since then, no other cases of KIAA1033 variants have been reported."

Reviewing the literature nine years after the founding report, the authors found no further published cases, establishing that the entity is known from a handful of families rather than from any cohort large enough to support a rate.

PMID:31953988 SUPPORT Human Clinical

"In 2011, KIAA1033/WASHC4 was associated with autosomal recessive intellectual disability (ARID) in a large consanguineous family comprising seven affected individuals with moderate ID and short stature."

Gives the size of the founding pedigree, the first component of the published case count.

🔀

Differential Diagnoses

3

Conditions with similar clinical presentations that must be differentiated from Intellectual Disability, Autosomal Recessive 43:

Ritscher-Schinzel (3C) syndrome and SPG8 (WASHC5/strumpellin)

Overlapping Features WASHC5, formerly KIAA0196, encodes strumpellin, a different subunit of the same WASH complex. Biallelic WASHC5 variants cause Ritscher-Schinzel / 3C syndrome with cranio-cerebello-cardiac malformations; heterozygous WASHC5 variants cause hereditary spastic paraplegia type 8. Neither is MRT43, and the similarity of the gene symbols and the shared complex make this the most likely confusion in the WASHC4 literature. The distinguishing features are the gene, the inheritance pattern for SPG8, and the malformation and spastic-paraparesis phenotypes, none of which characterise MRT43.

Distinguishing Features

Caused by WASHC5/KIAA0196, not WASHC4/KIAA1033
3C syndrome features cerebellar and cardiac malformations not reported in MRT43
SPG8 is dominantly inherited spastic paraplegia, not recessive intellectual disability

Show evidence (2 references)

PMID:31953988 SUPPORT Human Clinical

"Another member of the WASH complex, KIAA0196/WASHC5, has already been implicated in ARID with brain and cardiac malformations, under the designation of 3C or Ritscher-Schinzel syndrome (MIM#20210)."

The WASHC4 paper itself distinguishes its gene from the WASHC5 disorder, which is the distinction this entry records.

PMID:20498093 SUPPORT INDIRECT In Vitro

"Strumpellin is mutated in the human disease hereditary spastic paraplegia, and its link to WASH suggests that misregulation of actin dynamics on endosomes may play a role in this disorder."

Establishes the second, dominant strumpellin disorder that must not be conflated with MRT43. The quote is about strumpellin/WASHC5 in a biochemical study of the complex, not about WASHC4 patients, hence INDIRECT.

CCDC22-related attenuated 3C/Ritscher-Schinzel syndrome

Overlapping Features CCDC22 is a subunit of the CCC complex, which works together with the WASH complex on the same endosomal recycling step. Biallelic CCDC22 variants cause 3C/Ritscher-Schinzel syndrome, and a 2025 report describes an attenuated form without the cardiac or neuroanatomical malformations - a neurodevelopmental presentation that overlaps MRT43 more closely than the classical malformation syndrome does. The distinction is the gene and the complex, not the phenotype.

Distinguishing Features

Caused by CCDC22, a CCC-complex subunit, not by WASHC4 in the WASH complex
The classical form carries cranio-cerebello-cardiac malformations absent from MRT43
The attenuated form is defined by the absence of those malformations, which is what makes it the harder differential

Show evidence (2 references)

PMID:40448120 SUPPORT Human Clinical

"Here, we report a new CCDC22 missense mutation, p.E208K, that results in attenuated 3 C syndrome, without cardiac or neuroanatomical abnormalities."

Establishes the attenuated, malformation-free CCDC22 presentation that this differential guards against.

PMID:40448120 SUPPORT INDIRECT In Vitro

"CCC interacts with Retriever, a trimeric cargo recognition complex comprising VPS35L, VPS26C, and VPS29, and works closely with the WASH complex, a crucial regulator of branched actin polymerization at endosomal membranes."

States the functional relationship between the CCC complex and the WASH complex that WASHC4 belongs to, which is why the two disorders converge phenotypically. The quote is from the biochemical framing of the paper rather than from its patient description, hence INDIRECT.

🧫

Experimental Models

1

WASHC4-deficient patient dermal fibroblasts PRIMARY_CELL_CULTURE

Fibroblasts from a patient homozygous for a WASHC4 variant, analysed by quantitative proteomics. Human patient material, which is what makes it a useful complement to the mouse and zebrafish work.

Organism

human NCBITaxon:9606

Publication

PMID:34599609

Pathograph links

Impaired Autophagic Protein Clearance in Striated Muscle measures fidelity: low observes: molecular Proteomic profiling of the patient's fibroblasts identified dysregulation of proteins relevant to the neuromuscular axis, which is what directed the subsequent muscle-biopsy analysis.

Limitations: Fibroblasts are not muscle. The readout is a proteomic signature in a surrogate cell type from one patient, so it indicates rather than demonstrates the muscle mechanism.

Show evidence (1 reference)

PMID:34599609 SUPPORT In Vitro

"Proteomic profiling of fibroblasts of the WASHC4-deficient patient revealed dysregulation of proteins relevant for the maintenance of the neuromuscular axis."

States what was measured in this model and in which direction the interpretation runs.

🐁

Animal Models

2

SWIP P1019R knock-in mouse Genetic

A mouse carrying the exact missense allele found in the founding Omani pedigree. It is the only animal model of a specific human MRT43 allele, and it generated a prediction - progressive motor decline - that was subsequently confirmed in the patients.

Species

Mouse

Genotype

Washc4 p.Pro1019Arg knock-in, homozygous (SWIP-P1019R), CRISPR-generated

Genes

WASHC4 hgnc:29174

Publication

PMID:33749590

Pathograph links

WASH Complex Destabilization recapitulates fidelity: high observes: molecular Spatial proteomics of mutant mouse brain shows the same complex destabilisation demonstrated for the patient allele in cells.

Show evidence (1 reference)

PMID:33749590 SUPPORT Model Organism

"Quantitative spatial proteomics analysis of SWIPP1019R mouse brain reveals that this mutation destabilizes the WASH complex and uncovers significant perturbations in both endosomal and lysosomal pathways."

Establishes that the model reproduces the molecular lesion this node describes, in brain tissue.

Neuronal Endo-Lysosomal Dysfunction recapitulates fidelity: moderate observes: cellular Enlarged endosomes and lysosomes, lipofuscin accumulation and progressive caspase-3 activation in mutant brain.

Limitations: The corresponding neuropathology has not been examined in patients - there is no human brain tissue in the literature for this disorder - so the cellular phenotype is established only in the mouse.

Readouts

Endosome and lysosome size and lysosomal substrate accumulation

Direction: INCREASED

Interpretation: Morphological correlate of the sorting failure at the compartment level.

Show evidence (1 reference)

PMID:33749590 SUPPORT Model Organism

"Destabilization of the WASH complex leads to enlarged endosomes and lysosomes, with increased substrate accumulation at the lysosome."

Reports the measured direction of the compartment-size and substrate-accumulation readout.

Show evidence (1 reference)

PMID:33749590 SUPPORT Model Organism

"Cellular and histological analyses confirm that SWIPP1019R results in endo-lysosomal disruption and uncover indicators of neurodegeneration."

Supports treating this model as informative for the endo-lysosomal node.

Show evidence (1 reference)

PMID:33749590 SUPPORT Model Organism

"To uncover how dysfunction of endosomal SWIP leads to disease, we generate a mouse model of the human WASHC4c.3056C>G mutation."

Establishes that the model carries the human disease allele rather than a generic null.

Zebrafish washc4 loss-of-function Genetic

Zebrafish study of Washc4 as a VCP interactor. It is a muscle-proteostasis experiment, not a neurodevelopmental one, and it is the source of the prediction that WASHC4 loss would affect skeletal muscle - a prediction only confirmed in patients in 2022.

Species

Zebrafish

Genotype

washc4 targeted inactivation

Genes

WASHC4 hgnc:29174

Publication

PMID:30010465

Pathograph links

Impaired Autophagic Protein Clearance in Striated Muscle recapitulates fidelity: low observes: organism Washc4 inactivation impairs cardiac and skeletal muscle function and structure and interferes with autophagy, with ER stress but an intact ubiquitin-proteasome system.

Limitations: Zebrafish, and the study was designed around VCP/p97 myopathy rather than around intellectual disability; cardiac involvement of the kind reported here has not been described in WASHC4 patients, and the human muscle evidence is a single biopsy.

Show evidence (1 reference)

PMID:30010465 SUPPORT Model Organism

"We found that targeted inactivation of either Vcp or Washc4, led to progressive impairment of cardiac and skeletal muscle function, structure and cytoarchitecture without interfering with the differentiation of both organ systems."

Reports the muscle phenotype produced by loss of the MRT43 gene's ortholog.

Show evidence (1 reference)

PMID:34599609 SUPPORT INDIRECT Human Clinical

"Functional studies in a zebrafish model suggested that WASHC4 knockdown may also affect skeletal muscles by perturbing protein clearance."

A later human study describing what this zebrafish model established and why it was worth testing in patients; cited to record the model's role, not as independent muscle evidence.

{ }

Source YAML

click to show

name: Intellectual Disability, Autosomal Recessive 43
creation_date: "2026-09-07T00:00:00Z"
category: Genetic
description: >-
  Intellectual disability, autosomal recessive 43 (MRT43) is a rare Mendelian
  neurodevelopmental disorder caused by biallelic variants in WASHC4 (formerly
  KIAA1033), which encodes SWIP, one of the five subunits of the pentameric WASH
  complex. The WASH complex sits on the endosomal surface, where it activates
  the Arp2/3 complex to build the branched-actin patches that drive scission of
  the sorting tubules carrying cargo out of the endosome. Loss of SWIP
  destabilises the whole complex, and the resulting endosomal-sorting failure
  presents in brain as an endo-lysosomal trafficking defect. The founding report
  (2011) described a large consanguineous Omani family with seven affected
  members, moderate intellectual disability and short stature, and framed the
  entity as NON-syndromic; every subsequent report has described additional
  features - dysmorphism, macro- or microcephaly, skeletal anomalies,
  subependymal heterotopic nodules, sensorineural hearing loss, and skeletal
  muscle involvement - so the current literature calls the phenotype syndromic
  and heterogeneous. Fewer than fifteen patients from four families have been
  reported. A knock-in mouse carrying the human p.Pro1019Arg allele reproduces
  both the cognitive impairment and a progressive motor decline that was then
  found retrospectively in the patients, making MRT43 one of the few MRT-series
  entities with an experimentally worked mechanism rather than a gene assignment
  alone.
disease_term:
  preferred_term: intellectual disability, autosomal recessive 43
  term:
    id: MONDO:0014354
    label: intellectual disability, autosomal recessive 43
synonyms:
- intellectual developmental disorder, autosomal recessive 43
- mental retardation, autosomal recessive 43
- MRT43
- WASHC4 autosomal recessive non-syndromic intellectual disability
- autosomal recessive non-syndromic intellectual disability caused by mutation in WASHC4
- KIAA1033-related intellectual disability
- SWIP-related intellectual disability
parents:
- Autosomal Recessive Non-Syndromic Intellectual Disability
mappings:
  mondo_mappings:
  - term:
      id: MONDO:0014354
      label: intellectual disability, autosomal recessive 43
    mapping_predicate: skos:exactMatch
    mapping_source: MONDO
    mapping_justification: >-
      Primary MONDO identifier for this entry. MONDO:0014354 is a leaf term with
      no descendants and a single causal-gene assertion (RO:0004003 HGNC:29174,
      WASHC4), which is exactly the entity this file curates.
  - term:
      id: MONDO:0019502
      label: autosomal recessive non-syndromic intellectual disability
    mapping_predicate: skos:broadMatch
    mapping_source: MONDO
    mapping_justification: >-
      The asserted MONDO parent (rdfs:subClassOf) and the MONDO term of the
      class-level entry Autosomal_Recessive_Non-Syndromic_Intellectual_Disability.
      Recorded as broadMatch, not exactMatch: the class covers the whole MRT
      series. Note also that the "non-syndromic" element of that parent label is
      contradicted by the post-2011 WASHC4 literature; see notes.

classifications:
  harrisons_chapter:
  - classification_value: NEUROLOGIC
  - classification_value: GENETICS_ENVIRONMENT_DISEASE

references:
- reference: PMID:21498477
  title: "Identification of a novel candidate gene for non-syndromic autosomal recessive intellectual disability: the WASH complex member SWIP."
- reference: PMID:31953988
  title: "Novel KIAA1033/WASHC4 mutations in three patients with syndromic intellectual disability and a review of the literature."
- reference: PMID:34599609
  title: "Homozygous WASHC4 variant in two sisters causes a syndromic phenotype defined by dysmorphisms, intellectual disability, profound developmental disorder, and skeletal muscle involvement."
- reference: PMID:33749590
  title: "Genetic disruption of WASHC4 drives endo-lysosomal dysfunction and cognitive-movement impairments in mice and humans."
- reference: PMID:20498093
  title: "WASH and WAVE actin regulators of the Wiskott-Aldrich syndrome protein (WASP) family are controlled by analogous structurally related complexes."
- reference: PMID:30010465
  title: "Loss of the novel Vcp (valosin containing protein) interactor Washc4 interferes with autophagy-mediated proteostasis in striated muscle and leads to myopathy in vivo."
- reference: PMID:36995008
  title: "SWIP mediates retromer-independent membrane recruitment of the WASH complex."
- reference: PMID:40129681
  title: "Variants in WASHC3, a component of the WASH complex, cause short stature, variable neurodevelopmental abnormalities, and distinctive facial dysmorphism."
- reference: PMID:40448120
  title: "CCDC22 mutations that impair COMMD binding cause attenuated 3C/Ritscher-Schinzel syndrome."

inheritance:
- name: Autosomal recessive
  description: >-
    Two damaging WASHC4 alleles are required. The founding family was
    consanguineous and the affected members homozygous; later families carry
    compound heterozygous variants inherited one from each parent, and one
    further sibship is homozygous. No heterozygous carrier has been reported as
    affected.
  inheritance_term:
    preferred_term: Autosomal recessive inheritance
    term:
      id: HP:0000007
      label: Autosomal recessive inheritance
  evidence:
  - reference: PMID:31953988
    reference_title: "Novel KIAA1033/WASHC4 mutations in three patients with syndromic intellectual disability and a review of the literature."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Here we describe three additional patients (from two unrelated families)
      with syndromic ID due to compound heterozygous KIAA1033 variants
      ascertained by exome sequencing (ES).
    explanation: >-
      Biallelic (compound heterozygous) variants inherited one from each parent
      in two unrelated families is the recessive transmission pattern.
  - reference: PMID:21498477
    reference_title: "Identification of a novel candidate gene for non-syndromic autosomal recessive intellectual disability: the WASH complex member SWIP."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      In a large consanguineous family with autosomal recessive intellectual
      disability (ARID), we have combined homozygosity mapping, targeted exon
      enrichment and high-throughput sequencing to identify the underlying gene
      defect.
    explanation: >-
      The founding pedigree is consanguineous and was mapped by homozygosity
      mapping, which is only informative for a recessive, identical-by-descent
      locus.

prevalence:
- population: Worldwide, published cases
  measure_type: CASES_IN_LITERATURE
  prevalence_class: ULTRA_RARE
  notes: >-
    Fewer than fifteen affected individuals from four families are described in
    the primary literature as of 2026: seven in the 2011 Omani consanguineous
    pedigree, three from two unrelated families in 2020, and two sisters in
    2022. No population frequency estimate, birth prevalence, or carrier
    frequency has been published, and no Orphanet epidemiology record was
    available, so no numeric rate is asserted here.
  evidence:
  - reference: PMID:31953988
    reference_title: "Novel KIAA1033/WASHC4 mutations in three patients with syndromic intellectual disability and a review of the literature."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Since then, no other cases of KIAA1033 variants have been reported.
    explanation: >-
      Reviewing the literature nine years after the founding report, the authors
      found no further published cases, establishing that the entity is known
      from a handful of families rather than from any cohort large enough to
      support a rate.
  - reference: PMID:31953988
    reference_title: "Novel KIAA1033/WASHC4 mutations in three patients with syndromic intellectual disability and a review of the literature."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      In 2011, KIAA1033/WASHC4 was associated with autosomal recessive
      intellectual disability (ARID) in a large consanguineous family comprising
      seven affected individuals with moderate ID and short stature.
    explanation: >-
      Gives the size of the founding pedigree, the first component of the
      published case count.

genetic:
- name: WASHC4
  gene_term:
    preferred_term: WASHC4
    term:
      id: hgnc:29174
      label: WASHC4
  relationship_type: CAUSATIVE
  variant_origin: GERMLINE
  frequency: The only gene known to cause MRT43; all reported families carry biallelic WASHC4 variants.
  notes: >-
    Formerly KIAA1033; the protein is widely called SWIP (Strumpellin and WASH
    interacting protein). Reported disease alleles are the homozygous missense
    c.3056C>G p.(Pro1019Arg) in the founding Omani family, the compound
    heterozygous pairs p.(Gln442*)/p.(Asp1048Gly) and
    p.(Lys1079Arg)/p.(His503Arg), and a further homozygous variant in the 2022
    sibship. Both truncating and missense alleles occur, and the functionally
    characterised missense allele behaves as a loss of function by destabilising
    the complex rather than by any gain of activity.

    Complete Washc4 knockout in mouse is reported by MGI and IMPC to cause early
    embryonic phenotypes consistent with embryonic lethality, which would mean
    the human disease alleles are necessarily hypomorphic rather than true
    nulls. That constraint is recorded here without an evidence item: it is
    carried by mouse database phenotype annotations rather than by any statement
    in the WASHC4 disease literature, none of the cached references asserts it,
    and this repository has no MGI or IMPC ingest to quote from. It is stated as
    an unverified lead, not as a curated claim.
  variants:
  - name: c.3056C>G p.(Pro1019Arg)
    type: missense
    description: >-
      The founding allele, homozygous in the consanguineous Omani pedigree. It
      is the only WASHC4 disease allele that has been functionally characterised
      and modelled in an animal; it destabilises the WASH complex rather than
      abolishing the protein.
    evidence:
    - reference: PMID:33749590
      reference_title: "Genetic disruption of WASHC4 drives endo-lysosomal dysfunction and cognitive-movement impairments in mice and humans."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        In particular, an autosomal recessive mutation inWASHC4(c.3056C>G;
        p.Pro1019Arg) was identified in a cohort of children with non-syndromic
        intellectual disability
      explanation: >-
        Names the nucleotide and protein change of the founding allele and the
        cohort it was found in. The run-together spacing is the cached text's
        own, produced by the loss of italic markup around the gene symbol.
  - name: p.(Gln442*) / p.(Asp1048Gly)
    type: compound heterozygous stop-gain and missense
    description: >-
      Compound heterozygous pair in the two sisters of the 2020 report, one
      allele inherited from each parent.
    evidence:
    - reference: PMID:31953988
      reference_title: "Novel KIAA1033/WASHC4 mutations in three patients with syndromic intellectual disability and a review of the literature."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        Two sisters, aged 4 and 5.5 years, had a stop-gain and a missense
        variants, each inherited from one parent (p.(Gln442*) and
        p.(Asp1048Gly)).
      explanation: >-
        Names both alleles and states that each was inherited from one parent.
  - name: p.(Lys1079Arg) / p.(His503Arg)
    type: compound heterozygous missense
    description: >-
      Compound heterozygous missense pair in the third patient of the 2020
      report, a 34-year-old with mild intellectual disability, short stature and
      microcephaly.
    evidence:
    - reference: PMID:31953988
      reference_title: "Novel KIAA1033/WASHC4 mutations in three patients with syndromic intellectual disability and a review of the literature."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        The third patient was aged 34 years and had two missense variants, one
        inherited from each parent (p.(Lys1079Arg) and p.(His503Arg)).
      explanation: >-
        Names both alleles and the biparental inheritance in the third patient.
  - name: Unnamed homozygous WASHC4 variant (2022 sibship)
    description: >-
      A homozygous WASHC4 variant in the two siblings reported in 2022. The
      abstract states that the variant is homozygous but does not give its
      nucleotide or protein change, and the full text is not in the reference
      cache, so no allele designation is asserted here.
    evidence:
    - reference: PMID:34599609
      reference_title: "Homozygous WASHC4 variant in two sisters causes a syndromic phenotype defined by dysmorphisms, intellectual disability, profound developmental disorder, and skeletal muscle involvement."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        Here, we report two siblings with a homozygous WASHC4 variant expanding
        the clinical spectrum of the disease and provide a phenotypical
        comparison with cases reported in the literature.
      explanation: >-
        Establishes that this sibship is homozygous for a WASHC4 variant,
        without naming the allele.
  evidence:
  - reference: PMID:21498477
    reference_title: "Identification of a novel candidate gene for non-syndromic autosomal recessive intellectual disability: the WASH complex member SWIP."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      a member of the recently discovered WASH complex, which is involved in
      actin polymerization and multiple endosomal transport processes.
    explanation: >-
      Identifies the gene the founding study implicated (SWIP/WASHC4) and the
      complex and cellular process it belongs to.
  - reference: PMID:34599609
    reference_title: "Homozygous WASHC4 variant in two sisters causes a syndromic phenotype defined by dysmorphisms, intellectual disability, profound developmental disorder, and skeletal muscle involvement."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Recessive variants in WASHC4 are linked to intellectual disability
      complicated by poor language skills, short stature, and dysmorphic
      features.
    explanation: >-
      States the gene-disease relationship in its current, post-2011 form.

pathophysiology:
- name: Biallelic WASHC4 Loss of Function
  biological_scale: MOLECULAR
  description: >-
    Two damaging WASHC4 alleles - homozygous missense p.Pro1019Arg in the
    founding pedigree, truncating and missense compound heterozygous pairs in
    later families - reduce the amount of functional SWIP protein available to
    the WASH complex.
  genetic_context:
    genes:
    - preferred_term: WASHC4
      term:
        id: hgnc:29174
        label: WASHC4
    zygosity: HOMOZYGOUS
    variant_origin: GERMLINE
    functional_impact_category: LOSS_OF_FUNCTION
    description: >-
      The founding allele is homozygous by descent in a consanguineous pedigree;
      subsequent families are compound heterozygous. The functionally studied
      missense allele lowers SWIP protein level rather than creating a new
      activity, which is why it is classified as loss of function.
  genes:
  - preferred_term: WASHC4
    term:
      id: hgnc:29174
      label: WASHC4
  downstream:
  - target: WASH Complex Destabilization
    causal_link_type: DIRECT
    description: >-
      Reduced SWIP levels destabilise the assembled pentamer.
    evidence:
    - reference: PMID:21498477
      reference_title: "Identification of a novel candidate gene for non-syndromic autosomal recessive intellectual disability: the WASH complex member SWIP."
      supports: SUPPORT
      evidence_source: IN_VITRO
      snippet: >-
        In line with this assumption, we could show that this mutation leads to
        significantly reduced SWIP levels and to destabilization of the entire
        WASH complex.
      explanation: >-
        States the causal step itself: the patient mutation lowers SWIP and, as
        a consequence, destabilises the whole complex.
  evidence:
  - reference: PMID:21498477
    reference_title: "Identification of a novel candidate gene for non-syndromic autosomal recessive intellectual disability: the WASH complex member SWIP."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      In a large consanguineous family with autosomal recessive intellectual
      disability (ARID), we have combined homozygosity mapping, targeted exon
      enrichment and high-throughput sequencing to identify the underlying gene
      defect.
    explanation: >-
      Establishes that the initiating lesion is a biallelic autosomal locus
      identified by autozygosity mapping in an affected pedigree.

- name: WASH Complex Destabilization
  biological_scale: MOLECULAR
  description: >-
    SWIP/WASHC4 is one of five subunits of a roughly 500 kDa core complex that
    also contains WASH, Strumpellin (WASHC5), FAM21 (WASHC2) and CCDC53
    (WASHC3). Loss of SWIP does not merely remove one subunit: the assembled
    complex falls apart, so the WASH nucleation-promoting factor is lost from
    its site of action together with the subunits that anchor and regulate it.
  protein_complexes:
  - preferred_term: WASH complex
    term:
      id: GO:0071203
      label: WASH complex
  cellular_components:
  - preferred_term: endosome
    term:
      id: GO:0005768
      label: endosome
  downstream:
  - target: Loss of SWIP-Mediated Endosomal Membrane Anchoring
    causal_link_type: DIRECT
    description: >-
      SWIP is itself one of the two membrane anchors of the complex, so losing
      it removes an attachment point as well as a structural subunit.
  - target: Loss of Endosomal Branched-Actin Nucleation
    causal_link_type: DIRECT
    description: >-
      The complex exists to present the WASH nucleation-promoting factor to
      Arp2/3 at the endosome; a destabilised complex cannot do so.
    evidence:
    - reference: PMID:36995008
      reference_title: "SWIP mediates retromer-independent membrane recruitment of the WASH complex."
      supports: SUPPORT
      evidence_source: IN_VITRO
      snippet: >-
        The pentameric WASH complex facilitates endosomal protein sorting by
        activating Arp2/3, which in turn leads to the formation of F-actin
        patches specifically on the endosomal surface.
      explanation: >-
        States that branched-actin patch formation on the endosome is a function
        of the intact pentamer, so its destabilisation removes that output.
  evidence:
  - reference: PMID:20498093
    reference_title: "WASH and WAVE actin regulators of the Wiskott-Aldrich syndrome protein (WASP) family are controlled by analogous structurally related complexes."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      Here we show that WASH functions in cells within a 500 kDa core complex
      containing Strumpellin, FAM21, KIAA1033 (SWIP), and CCDC53.
    explanation: >-
      Defines the complex whose destabilisation this node describes and places
      KIAA1033/SWIP - the MRT43 gene product - inside it.
  - reference: PMID:33749590
    reference_title: "Genetic disruption of WASHC4 drives endo-lysosomal dysfunction and cognitive-movement impairments in mice and humans."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      Quantitative spatial proteomics analysis of SWIPP1019R mouse brain reveals
      that this mutation destabilizes the WASH complex and uncovers significant
      perturbations in both endosomal and lysosomal pathways.
    explanation: >-
      Confirms in brain tissue of an animal carrying the human patient allele
      that the complex is destabilised, not just in cultured cells.

- name: Loss of SWIP-Mediated Endosomal Membrane Anchoring
  biological_scale: MOLECULAR
  description: >-
    The textbook route by which the WASH complex reaches the endosomal membrane
    is the FAM21-VPS35 interaction with retromer. SWIP provides a second,
    retromer-INDEPENDENT anchor, binding phosphoinositides directly, with
    PI(3,5)P2 the species that matters for endosomal binding. Loss of SWIP
    therefore removes an anchor that retromer cannot substitute for. This is a
    deliberate qualification of the common shorthand that WASH acts only
    downstream of retromer.
  molecular_functions:
  - preferred_term: phosphatidylinositol-3,5-bisphosphate binding
    term:
      id: GO:0080025
      label: phosphatidylinositol-3,5-bisphosphate binding
  cellular_components:
  - preferred_term: endosome
    term:
      id: GO:0005768
      label: endosome
  downstream:
  - target: Loss of Endosomal Branched-Actin Nucleation
    causal_link_type: DIRECT
    description: >-
      A complex that cannot be held at the endosomal surface cannot nucleate
      actin there.
  evidence:
  - reference: PMID:36995008
    reference_title: "SWIP mediates retromer-independent membrane recruitment of the WASH complex."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      The retromer-independent membrane anchor is directly mediated by the
      subunit SWIP.
    explanation: >-
      Directly attributes a membrane-anchoring function to the MRT43 gene
      product itself, which is what makes its loss more than the loss of a
      structural filler subunit.
  - reference: PMID:36995008
    reference_title: "SWIP mediates retromer-independent membrane recruitment of the WASH complex."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      It is generally accepted that WASH complex attaches to the endosomal
      membrane via the interaction of its subunit FAM21 with the retromer
      subunit VPS35.
    explanation: >-
      Records the retromer-dependent route this node is contrasted with, so the
      qualification in the node description is attributable rather than
      editorial.
  notes: >-
    Cell-biological work in cultured cells on the SWIP protein, not on patient
    material. It is included because it is about WASHC4/SWIP itself; the
    disease-level consequence is inferred, and the downstream edges carry their
    own evidence.

- name: Loss of Endosomal Branched-Actin Nucleation
  biological_scale: CELLULAR
  description: >-
    The WASH complex's output is activation of Arp2/3 on the endosomal surface,
    producing localised branched-actin patches. Without it, the force that
    shapes and pinches the sorting tubules leaving the endosome is not
    generated.
  biological_processes:
  - preferred_term: Arp2/3 complex-mediated actin nucleation
    term:
      id: GO:0034314
      label: Arp2/3 complex-mediated actin nucleation
    modifier: DECREASED
  - preferred_term: actin filament polymerization
    term:
      id: GO:0030041
      label: actin filament polymerization
    modifier: DECREASED
  molecular_functions:
  - preferred_term: Arp2/3 complex binding
    term:
      id: GO:0071933
      label: Arp2/3 complex binding
  cellular_components:
  - preferred_term: early endosome
    term:
      id: GO:0005769
      label: early endosome
  downstream:
  - target: Failed Endosomal Cargo Sorting and Tubule Fission
    causal_link_type: DIRECT
    evidence:
    - reference: PMID:31953988
      reference_title: "Novel KIAA1033/WASHC4 mutations in three patients with syndromic intellectual disability and a review of the literature."
      supports: SUPPORT
      evidence_source: OTHER
      snippet: >-
        The WASH complex is involved in the regulation of the fission of tubules
        that serve as transport intermediates during endosome sorting.
      explanation: >-
        States the step from WASH complex activity to tubule fission during
        endosome sorting, which is the edge drawn here.
  evidence:
  - reference: PMID:34599609
    reference_title: "Homozygous WASHC4 variant in two sisters causes a syndromic phenotype defined by dysmorphisms, intellectual disability, profound developmental disorder, and skeletal muscle involvement."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      The protein encoded by WASHC4 is part of the Wiskott-Aldrich syndrome
      protein and SCAR homolog family, co-localizes with actin in cells, and
      promotes Arp2/3-dependent actin polymerization in vitro.
    explanation: >-
      Attributes Arp2/3-dependent actin polymerisation to the WASHC4 gene
      product specifically, so its loss is expected to reduce that activity.

- name: Failed Endosomal Cargo Sorting and Tubule Fission
  biological_scale: CELLULAR
  description: >-
    Cargo that should leave the sorting endosome in a scission-competent tubule
    - for recycling to the surface or retrograde delivery to the Golgi - is not
    retrieved efficiently. The endosomal and lysosomal compartments enlarge and
    substrate accumulates.
  biological_processes:
  - preferred_term: endosomal transport
    term:
      id: GO:0016197
      label: endosomal transport
    modifier: DECREASED
  - preferred_term: endocytic recycling
    term:
      id: GO:0032456
      label: endocytic recycling
    modifier: DECREASED
  - preferred_term: retrograde transport, endosome to Golgi
    term:
      id: GO:0042147
      label: retrograde transport, endosome to Golgi
    modifier: DECREASED
  - preferred_term: endosome organization
    term:
      id: GO:0007032
      label: endosome organization
  downstream:
  - target: Neuronal Endo-Lysosomal Dysfunction
    causal_link_type: DIRECT
    evidence:
    - reference: PMID:33749590
      reference_title: "Genetic disruption of WASHC4 drives endo-lysosomal dysfunction and cognitive-movement impairments in mice and humans."
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: >-
        Cellular and histological analyses confirm that SWIPP1019R results in
        endo-lysosomal disruption and uncover indicators of neurodegeneration.
      explanation: >-
        Links the sorting defect produced by the patient allele to disruption of
        the endo-lysosomal system in brain tissue.
  - target: Impaired Autophagic Protein Clearance in Striated Muscle
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: >-
      The muscle arm is supported by zebrafish knockdown and by patient muscle
      and fibroblast proteomics, not by a demonstrated step from endosomal
      sorting to autophagic flux in human muscle.
  evidence:
  - reference: PMID:33749590
    reference_title: "Genetic disruption of WASHC4 drives endo-lysosomal dysfunction and cognitive-movement impairments in mice and humans."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      Destabilization of the WASH complex leads to enlarged endosomes and
      lysosomes, with increased substrate accumulation at the lysosome.
    explanation: >-
      Describes the morphological and cargo-handling consequence at the
      compartment level that this node names.

- name: Neuronal Endo-Lysosomal Dysfunction
  biological_scale: CELLULAR
  description: >-
    In brain the sorting failure presents as a disturbed endo-lysosomal axis:
    enlarged endosomes and lysosomes, raised lysosomal enzyme levels, ER stress,
    accumulation of lipofuscin-like residual bodies, and progressive activation
    of apoptotic markers. The pattern is degenerative rather than purely
    developmental, which matters because MRT-series entities are usually treated
    as static encephalopathies.
  cell_types:
  - preferred_term: neuron
    term:
      id: CL:0000540
      label: neuron
  locations:
  - preferred_term: brain
    term:
      id: UBERON:0000955
      label: brain
  cellular_components:
  - preferred_term: lysosome
    term:
      id: GO:0005764
      label: lysosome
  biological_processes:
  - preferred_term: lysosome organization
    term:
      id: GO:0007040
      label: lysosome organization
  downstream:
  - target: Intellectual Disability
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: >-
      The cognitive phenotype is attributed to the endo-lysosomal defect, but
      the intervening circuit-level step is not established.
    evidence:
    - reference: PMID:33749590
      reference_title: "Genetic disruption of WASHC4 drives endo-lysosomal dysfunction and cognitive-movement impairments in mice and humans."
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: >-
        Combined, these findings support the model that WASH complex
        destabilization, resulting from SWIPP1019R, drives cognitive and motor
        impairments via endo-lysosomal dysfunction in the brain.
      explanation: >-
        The authors state the causal model this edge encodes; the evidence is a
        mouse carrying the human allele, so the claim about human cognition is
        an inference from that model plus the patients' known phenotype.
  - target: Movement Impairment
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - reference: PMID:33749590
      reference_title: "Genetic disruption of WASHC4 drives endo-lysosomal dysfunction and cognitive-movement impairments in mice and humans."
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: >-
        We find that SWIPP1019R not only impacts cognition, but also causes
        significant progressive motor deficits in mice.
      explanation: >-
        Establishes the motor arm of the same causal model in the knock-in
        animal.
  evidence:
  - reference: PMID:33749590
    reference_title: "Genetic disruption of WASHC4 drives endo-lysosomal dysfunction and cognitive-movement impairments in mice and humans."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      Cellular analyses confirm a significant impact on neuronal endo-lysosomal
      trafficking in vitro and in vivo, with evidence of lipofuscin accumulation
      and progressive apoptosis activation, molecular phenotypes that are
      indicative of neurodegenerative pathology.
    explanation: >-
      Names the specific cellular findings - lipofuscin accumulation, apoptosis
      activation - that this node asserts.

- name: Impaired Autophagic Protein Clearance in Striated Muscle
  biological_scale: CELLULAR
  description: >-
    Outside the nervous system, WASHC4 loss disturbs protein clearance in
    striated muscle. Zebrafish washc4 inactivation causes ER stress and
    interferes with autophagy without impairing the ubiquitin-proteasome system,
    and proteins relevant to muscle function are dysregulated in a patient
    muscle biopsy and in patient fibroblasts.
  cell_types:
  - preferred_term: muscle cell
    term:
      id: CL:0000187
      label: muscle cell
  locations:
  - preferred_term: skeletal muscle tissue
    term:
      id: UBERON:0001134
      label: skeletal muscle tissue
  biological_processes:
  - preferred_term: autophagy
    term:
      id: GO:0006914
      label: autophagy
    modifier: DECREASED
  downstream:
  - target: Skeletal Muscle Involvement
    causal_link_type: DIRECT
    evidence:
    - reference: PMID:34599609
      reference_title: "Homozygous WASHC4 variant in two sisters causes a syndromic phenotype defined by dysmorphisms, intellectual disability, profound developmental disorder, and skeletal muscle involvement."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        Immunostaining on a muscle biopsy derived from the same patient
        confirmed dysregulation of proteins relevant for proper muscle function,
        thus highlighting an affliction of muscle cells upon loss of functional
        WASHC4.
      explanation: >-
        Connects loss of WASHC4 to a demonstrated abnormality in patient muscle
        tissue, which is the phenotype this edge points at.
  evidence:
  - reference: PMID:30010465
    reference_title: "Loss of the novel Vcp (valosin containing protein) interactor Washc4 interferes with autophagy-mediated proteostasis in striated muscle and leads to myopathy in vivo."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      Notably, loss of Vcp resulted in compromised protein degradation via the
      proteasome and the macroautophagy/autophagy machinery, whereas Washc4
      deficiency did not affect the function of the ubiquitin-proteasome system
      (UPS) but caused ER stress and interfered with autophagy function in vivo.
    explanation: >-
      Specifies the arm of proteostasis that Washc4 loss affects in vivo -
      autophagy and ER stress, not the proteasome - which is the claim this node
      makes.
  notes: >-
    Kept as a separate branch rather than folded into the neuronal chain because
    its evidence base is different (zebrafish plus one patient biopsy) and
    because skeletal muscle involvement was explicitly absent from the reported
    human phenotype until 2022.

phenotypes:
- name: Intellectual Disability
  category: Nervous System
  description: >-
    The defining feature. Severity spans moderate in the founding pedigree to
    mild in one later patient and "learning disabilities" in two others, so the
    entry does not bind a severity-specific HPO term.
  phenotype_term:
    preferred_term: Intellectual disability
    term:
      id: HP:0001249
      label: Intellectual disability
  frequency: VERY_FREQUENT
  sequelae:
  - target: Delayed Speech and Language Development
    description: >-
      Language difficulty is described as a complication of the intellectual
      disability rather than as an independent deficit.
    evidence:
    - reference: PMID:34599609
      reference_title: "Homozygous WASHC4 variant in two sisters causes a syndromic phenotype defined by dysmorphisms, intellectual disability, profound developmental disorder, and skeletal muscle involvement."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        Recessive variants in WASHC4 are linked to intellectual disability
        complicated by poor language skills, short stature, and dysmorphic
        features.
      explanation: >-
        The wording "intellectual disability complicated by poor language
        skills" is what this sequela edge encodes.
  evidence:
  - reference: PMID:21498477
    reference_title: "Identification of a novel candidate gene for non-syndromic autosomal recessive intellectual disability: the WASH complex member SWIP."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      In a large consanguineous family with autosomal recessive intellectual
      disability (ARID), we have combined homozygosity mapping, targeted exon
      enrichment and high-throughput sequencing to identify the underlying gene
      defect.
    explanation: >-
      Intellectual disability is the ascertaining phenotype of the founding
      pedigree.
  - reference: PMID:31953988
    reference_title: "Novel KIAA1033/WASHC4 mutations in three patients with syndromic intellectual disability and a review of the literature."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      In 2011, KIAA1033/WASHC4 was associated with autosomal recessive
      intellectual disability (ARID) in a large consanguineous family comprising
      seven affected individuals with moderate ID and short stature.
    explanation: >-
      Records the severity band in the largest reported family.
  - reference: PMID:31953988
    reference_title: "Novel KIAA1033/WASHC4 mutations in three patients with syndromic intellectual disability and a review of the literature."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      This patient presented with mild ID, short stature, and microcephaly.
    explanation: >-
      Documents the mild end of the severity range, which is why no
      severity-specific HPO term is bound.

- name: Delayed Speech and Language Development
  category: Voice
  description: >-
    Poor language skills accompany the intellectual disability across reported
    patients.
  phenotype_term:
    preferred_term: Delayed speech and language development
    term:
      id: HP:0000750
      label: Delayed speech and language development
  evidence:
  - reference: PMID:34599609
    reference_title: "Homozygous WASHC4 variant in two sisters causes a syndromic phenotype defined by dysmorphisms, intellectual disability, profound developmental disorder, and skeletal muscle involvement."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Recessive variants in WASHC4 are linked to intellectual disability
      complicated by poor language skills, short stature, and dysmorphic
      features.
    explanation: >-
      Names poor language skills as part of the established WASHC4 phenotype.

- name: Short Stature
  category: Growth
  description: >-
    Present in the founding pedigree and in one of the three 2020 patients, and
    named as an established feature of the disorder in 2022.
  phenotype_term:
    preferred_term: Short stature
    term:
      id: HP:0004322
      label: Short stature
  frequency: FREQUENT
  evidence:
  - reference: PMID:31953988
    reference_title: "Novel KIAA1033/WASHC4 mutations in three patients with syndromic intellectual disability and a review of the literature."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      In 2011, KIAA1033/WASHC4 was associated with autosomal recessive
      intellectual disability (ARID) in a large consanguineous family comprising
      seven affected individuals with moderate ID and short stature.
    explanation: >-
      Short stature is reported together with the intellectual disability in the
      founding family.
  - reference: PMID:34599609
    reference_title: "Homozygous WASHC4 variant in two sisters causes a syndromic phenotype defined by dysmorphisms, intellectual disability, profound developmental disorder, and skeletal muscle involvement."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Recessive variants in WASHC4 are linked to intellectual disability
      complicated by poor language skills, short stature, and dysmorphic
      features.
    explanation: >-
      Confirms short stature as an established feature of the gene-disease
      relationship, independent of the founding report.

- name: Dysmorphic Facial Features
  category: Head and Neck
  description: >-
    Dysmorphism is reported in the 2020 and 2022 patients and is one of the
    findings that moved the entity out of the non-syndromic category. No single
    recognisable gestalt has been defined, so the general HPO term is bound.
  phenotype_term:
    preferred_term: Dysmorphic facial features
    term:
      id: HP:0001999
      label: Abnormal facial shape
  evidence:
  - reference: PMID:31953988
    reference_title: "Novel KIAA1033/WASHC4 mutations in three patients with syndromic intellectual disability and a review of the literature."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Both had learning disabilities, macrocephaly, dysmorphic features,
      skeletal anomalies, and subependymal heterotopic nodules.
    explanation: >-
      Reports dysmorphic features in two affected sisters.
  - reference: PMID:34599609
    reference_title: "Homozygous WASHC4 variant in two sisters causes a syndromic phenotype defined by dysmorphisms, intellectual disability, profound developmental disorder, and skeletal muscle involvement."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Recessive variants in WASHC4 are linked to intellectual disability
      complicated by poor language skills, short stature, and dysmorphic
      features.
    explanation: >-
      Independent confirmation that dysmorphism belongs to the WASHC4 phenotype.

- name: Macrocephaly
  category: Head and Neck
  description: >-
    Reported in the two sisters with compound heterozygous variants. Head size
    is not consistent across the disorder - a different patient in the same
    report is microcephalic.
  phenotype_term:
    preferred_term: Macrocephaly
    term:
      id: HP:0000256
      label: Macrocephaly
  frequency: OCCASIONAL
  evidence:
  - reference: PMID:31953988
    reference_title: "Novel KIAA1033/WASHC4 mutations in three patients with syndromic intellectual disability and a review of the literature."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Both had learning disabilities, macrocephaly, dysmorphic features,
      skeletal anomalies, and subependymal heterotopic nodules.
    explanation: >-
      Directly reports macrocephaly in two affected siblings.

- name: Microcephaly
  category: Head and Neck
  description: >-
    Reported in the third 2020 patient, alongside mild intellectual disability
    and short stature. Curated separately from macrocephaly because the two are
    opposite findings in different patients, not a single variable trait with an
    agreed direction.
  phenotype_term:
    preferred_term: Microcephaly
    term:
      id: HP:0000252
      label: Microcephaly
  frequency: OCCASIONAL
  evidence:
  - reference: PMID:31953988
    reference_title: "Novel KIAA1033/WASHC4 mutations in three patients with syndromic intellectual disability and a review of the literature."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      This patient presented with mild ID, short stature, and microcephaly.
    explanation: >-
      Directly reports microcephaly in one patient.

- name: Subependymal Nodular Heterotopia
  category: Nervous System
  description: >-
    Subependymal heterotopic nodules were found in both affected sisters
    reported in 2020. Bound to the HPO term for periventricular nodular
    heterotopia, which is the same lesion under the term HPO uses.
  phenotype_term:
    preferred_term: Subependymal heterotopic nodules
    term:
      id: HP:0032388
      label: Periventricular nodular heterotopia
  frequency: OCCASIONAL
  evidence:
  - reference: PMID:31953988
    reference_title: "Novel KIAA1033/WASHC4 mutations in three patients with syndromic intellectual disability and a review of the literature."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Both had learning disabilities, macrocephaly, dysmorphic features,
      skeletal anomalies, and subependymal heterotopic nodules.
    explanation: >-
      Directly reports the neuronal migration abnormality in two siblings.

- name: Skeletal Anomalies
  category: Musculoskeletal
  description: >-
    Reported without further specification in the two sisters described in 2020,
    so only the general skeletal HPO term can be bound.
  phenotype_term:
    preferred_term: Skeletal anomalies
    term:
      id: HP:0000924
      label: Abnormality of the skeletal system
  frequency: OCCASIONAL
  evidence:
  - reference: PMID:31953988
    reference_title: "Novel KIAA1033/WASHC4 mutations in three patients with syndromic intellectual disability and a review of the literature."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Both had learning disabilities, macrocephaly, dysmorphic features,
      skeletal anomalies, and subependymal heterotopic nodules.
    explanation: >-
      Reports skeletal anomalies as part of the syndromic presentation.

- name: Sensorineural Hearing Loss
  category: Ear
  description: >-
    Bilateral sensorineural hearing loss reported in one patient, in whom it
    accompanied congenital absence of the right internal carotid artery. A
    single observation; not established as a recurrent feature.
  phenotype_term:
    preferred_term: Bilateral sensorineural hearing loss
    term:
      id: HP:0000407
      label: Sensorineural hearing impairment
  frequency: VERY_RARE
  evidence:
  - reference: PMID:31953988
    reference_title: "Novel KIAA1033/WASHC4 mutations in three patients with syndromic intellectual disability and a review of the literature."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      In addition, the younger sibling had a congenital absence of the right
      internal carotid and bilateral sensorineural hearing loss.
    explanation: >-
      Single-patient report of bilateral sensorineural hearing loss in a
      WASHC4-biallelic individual.

- name: Congenital Absence of the Internal Carotid Artery
  category: Cardiovascular
  description: >-
    Congenital absence of the right internal carotid artery in one patient, the
    younger of the two sisters reported in 2020, in whom it accompanied
    bilateral sensorineural hearing loss. A single observation; not established
    as a recurrent feature.
  phenotype_term:
    preferred_term: Congenital absence of the right internal carotid artery
    term:
      id: HP:3000062
      label: Abnormal internal carotid artery morphology
  frequency: VERY_RARE
  evidence:
  - reference: PMID:31953988
    reference_title: "Novel KIAA1033/WASHC4 mutations in three patients with syndromic intellectual disability and a review of the literature."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      In addition, the younger sibling had a congenital absence of the right
      internal carotid and bilateral sensorineural hearing loss.
    explanation: >-
      Single-patient report of congenital absence of the right internal carotid
      artery in a WASHC4-biallelic individual. This is the vascular half of the
      same sentence whose auditory half supports the hearing-loss phenotype.
  notes: >-
    Bound to HP:3000062 Abnormal internal carotid artery morphology, which is a
    parent term. HPO has no term for agenesis or aplasia of the internal carotid
    artery: the nearest candidates are HP:0005290 Internal carotid artery
    hypoplasia, which asserts a hypoplastic rather than an absent vessel, and
    HP:0031604 Agenesis of the carotid canal, which is the bony canal rather
    than the artery. Neither is what the source reports, so the accurate parent
    is bound and the specific finding is carried in preferred_term.

- name: Movement Impairment
  category: Nervous System
  description: >-
    Motor deficits, comprising the specific signs curated separately below. The
    finding was made first in the knock-in mouse and then recovered from the
    patients' records by retrospective review, so its ascertainment in humans is
    retrospective rather than prospective. Progression is established in the
    mouse and is not established in the patients, whose follow-up to a mean age
    of 21 showed no clear worsening; the node is therefore named for the deficit
    rather than for a course, and the disagreement is carried by the
    mrt43_static_or_degenerative discussion.
  phenotype_term:
    preferred_term: Movement abnormality
    term:
      id: HP:0100022
      label: Abnormality of movement
  evidence:
  - reference: PMID:33749590
    reference_title: "Genetic disruption of WASHC4 drives endo-lysosomal dysfunction and cognitive-movement impairments in mice and humans."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      A retrospective analysis of SWIPP1019R patients reveals similar movement
      deficits in humans.
    explanation: >-
      The human observation for this phenotype; the study is a mouse paper, but
      this specific sentence reports a retrospective analysis of the patients.
  - reference: PMID:33749590
    reference_title: "Genetic disruption of WASHC4 drives endo-lysosomal dysfunction and cognitive-movement impairments in mice and humans."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    directness: INDIRECT
    snippet: >-
      Interestingly, while gait parameters of the mice were largely
      indistinguishable across genotypes at adolescence, a striking difference
      was seen when the same mice were aged to adulthood
    explanation: >-
      Supports the progressive character of the phenotype - gait is normal in
      adolescent mutants and abnormal in the same animals as adults - but in the
      knock-in mouse rather than in patients, whose human data are a
      retrospective chart review.
  sequelae:
  - target: Dysmetria
  - target: Dysdiadochokinesis
  - target: Dysarthria
  - target: Delayed Fine Motor Development
    evidence:
    - reference: PMID:33749590
      reference_title: "Genetic disruption of WASHC4 drives endo-lysosomal dysfunction and cognitive-movement impairments in mice and humans."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        with notable fine motor difficulties, dysmetria, dysdiadochokinesia,
        and mild dysarthria on clinical exam
      explanation: >-
        One clinical-examination sentence enumerates the specific signs that
        make up the motor impairment in these patients, which is what these
        four edges record. The edges are constituent rather than sequential -
        each sign is a component of the movement impairment, not a later
        consequence of it - and sequelae is the only slot available for that
        relation.

- name: Dysmetria
  category: Nervous System
  description: >-
    Inaccurate targeting of voluntary movement, recorded on clinical
    examination of the founding pedigree's patients in the 2021
    retrospective review.
  phenotype_term:
    preferred_term: Dysmetria
    term:
      id: HP:0001310
      label: Dysmetria
  evidence:
  - reference: PMID:33749590
    reference_title: "Genetic disruption of WASHC4 drives endo-lysosomal dysfunction and cognitive-movement impairments in mice and humans."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      with notable fine motor difficulties, dysmetria, dysdiadochokinesia,
      and mild dysarthria on clinical exam
    explanation: >-
      The clinical-examination sentence names dysmetria among the motor signs
      found on re-evaluation of the human patients.

- name: Dysdiadochokinesis
  category: Nervous System
  description: >-
    Impaired rapid alternating movement, recorded on the same clinical
    examination.
  phenotype_term:
    preferred_term: Dysdiadochokinesia
    term:
      id: HP:0002075
      label: Dysdiadochokinesis
  evidence:
  - reference: PMID:33749590
    reference_title: "Genetic disruption of WASHC4 drives endo-lysosomal dysfunction and cognitive-movement impairments in mice and humans."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      with notable fine motor difficulties, dysmetria, dysdiadochokinesia,
      and mild dysarthria on clinical exam
    explanation: >-
      The same sentence names dysdiadochokinesia among the examination
      findings.

- name: Dysarthria
  category: Nervous System
  description: >-
    Mild dysarthria on clinical examination. This is a motor speech sign
    and is distinct from the language delay curated separately; the source
    qualifies it as mild.
  phenotype_term:
    preferred_term: Mild dysarthria
    term:
      id: HP:0001260
      label: Dysarthria
  evidence:
  - reference: PMID:33749590
    reference_title: "Genetic disruption of WASHC4 drives endo-lysosomal dysfunction and cognitive-movement impairments in mice and humans."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      with notable fine motor difficulties, dysmetria, dysdiadochokinesia,
      and mild dysarthria on clinical exam
    explanation: >-
      The same sentence reports mild dysarthria on clinical exam.

- name: Delayed Fine Motor Development
  category: Nervous System
  description: >-
    Notable fine motor difficulty, reported alongside the cerebellar-type
    signs in the same retrospective examination.
  phenotype_term:
    preferred_term: Fine motor difficulties
    term:
      id: HP:0010862
      label: Delayed fine motor development
  evidence:
  - reference: PMID:33749590
    reference_title: "Genetic disruption of WASHC4 drives endo-lysosomal dysfunction and cognitive-movement impairments in mice and humans."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      with notable fine motor difficulties, dysmetria, dysdiadochokinesia,
      and mild dysarthria on clinical exam
    explanation: >-
      The same sentence reports notable fine motor difficulties. The HPO term
      is developmental in framing while the source describes examination
      findings at a mean age of 10.4 years, so the binding is the closest
      available rather than an exact restatement.

- name: Skeletal Muscle Involvement
  category: Musculoskeletal
  description: >-
    Dysregulation of muscle-relevant proteins on immunostaining of a patient
    muscle biopsy, reported for the first time in 2022 and explicitly absent
    from earlier descriptions.
  phenotype_term:
    preferred_term: Skeletal muscle involvement
    term:
      id: HP:0003198
      label: Myopathy
  frequency: OCCASIONAL
  evidence:
  - reference: PMID:34599609
    reference_title: "Homozygous WASHC4 variant in two sisters causes a syndromic phenotype defined by dysmorphisms, intellectual disability, profound developmental disorder, and skeletal muscle involvement."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The proteomic analysis confirmed key molecular players in vitro and
      highlighted, for the first time, the involvement of skeletal muscle in
      patients.
    explanation: >-
      States that skeletal muscle involvement was demonstrated in patients.
  - reference: PMID:34599609
    reference_title: "Homozygous WASHC4 variant in two sisters causes a syndromic phenotype defined by dysmorphisms, intellectual disability, profound developmental disorder, and skeletal muscle involvement."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      However, skeletal muscle involvement has not been reported so far in
      patients, and precise biochemical studies allowing a deeper understanding
      of the molecular etiology of the disease are still lacking.
    explanation: >-
      The same paper's statement of the prior state of knowledge, which is why
      this phenotype is marked OCCASIONAL and dated to 2022 rather than treated
      as a long-established feature.
  notes: >-
    Bound to HP:0003198 Myopathy, which is broader than what was shown. The
    evidence is biopsy immunostaining and proteomics, not a clinical myopathy
    syndrome with weakness, raised creatine kinase and myopathic EMG in a
    series; the preferred_term is kept at the weaker "Skeletal muscle
    involvement" for that reason.

animal_models:
- name: SWIP P1019R knock-in mouse
  species: Mouse
  genotype: Washc4 p.Pro1019Arg knock-in, homozygous (SWIP-P1019R), CRISPR-generated
  category: Genetic
  publication: PMID:33749590
  description: >-
    A mouse carrying the exact missense allele found in the founding Omani
    pedigree. It is the only animal model of a specific human MRT43 allele, and
    it generated a prediction - progressive motor decline - that was
    subsequently confirmed in the patients.
  genes:
  - preferred_term: WASHC4
    term:
      id: hgnc:29174
      label: WASHC4
  modeled_mechanisms:
  - target: WASH Complex Destabilization
    relationship: RECAPITULATES
    fidelity: HIGH
    model_scale: MOLECULAR
    description: >-
      Spatial proteomics of mutant mouse brain shows the same complex
      destabilisation demonstrated for the patient allele in cells.
    evidence:
    - reference: PMID:33749590
      reference_title: "Genetic disruption of WASHC4 drives endo-lysosomal dysfunction and cognitive-movement impairments in mice and humans."
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: >-
        Quantitative spatial proteomics analysis of SWIPP1019R mouse brain
        reveals that this mutation destabilizes the WASH complex and uncovers
        significant perturbations in both endosomal and lysosomal pathways.
      explanation: >-
        Establishes that the model reproduces the molecular lesion this node
        describes, in brain tissue.
  - target: Neuronal Endo-Lysosomal Dysfunction
    relationship: RECAPITULATES
    fidelity: MODERATE
    model_scale: CELLULAR
    description: >-
      Enlarged endosomes and lysosomes, lipofuscin accumulation and progressive
      caspase-3 activation in mutant brain.
    limitations: >-
      The corresponding neuropathology has not been examined in patients - there
      is no human brain tissue in the literature for this disorder - so the
      cellular phenotype is established only in the mouse.
    readouts:
    - name: Endosome and lysosome size and lysosomal substrate accumulation
      target: Neuronal Endo-Lysosomal Dysfunction
      direction: INCREASED
      interpretation: >-
        Morphological correlate of the sorting failure at the compartment level.
      evidence:
      - reference: PMID:33749590
        reference_title: "Genetic disruption of WASHC4 drives endo-lysosomal dysfunction and cognitive-movement impairments in mice and humans."
        supports: SUPPORT
        evidence_source: MODEL_ORGANISM
        snippet: >-
          Destabilization of the WASH complex leads to enlarged endosomes and
          lysosomes, with increased substrate accumulation at the lysosome.
        explanation: >-
          Reports the measured direction of the compartment-size and
          substrate-accumulation readout.
    evidence:
    - reference: PMID:33749590
      reference_title: "Genetic disruption of WASHC4 drives endo-lysosomal dysfunction and cognitive-movement impairments in mice and humans."
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: >-
        Cellular and histological analyses confirm that SWIPP1019R results in
        endo-lysosomal disruption and uncover indicators of neurodegeneration.
      explanation: >-
        Supports treating this model as informative for the endo-lysosomal node.
  - target: Movement Impairment
    relationship: RECAPITULATES
    fidelity: MODERATE
    model_scale: ORGANISM
    description: >-
      Rotarod, gait and strength decline with age in mutant mice; the equivalent
      human deficits were then found on retrospective chart review.
    limitations: >-
      Rodent rotarod and gait measures are not the clinical movement examination
      used in the patients, and the human confirmation is retrospective, so the
      correspondence is at the level of "movement is affected and worsens",
      not of a matched motor phenotype.
    readouts:
    - name: TreadScan gait parameters at adolescence versus adulthood
      target: Movement Impairment
      direction: ALTERED
      interpretation: >-
        Behavioural correlate of the progressive motor arm of the phenotype:
        gait is indistinguishable from wild type in adolescence and clearly
        abnormal in the same animals as adults.
      evidence:
      - reference: PMID:33749590
        reference_title: "Genetic disruption of WASHC4 drives endo-lysosomal dysfunction and cognitive-movement impairments in mice and humans."
        supports: SUPPORT
        evidence_source: MODEL_ORGANISM
        snippet: >-
          Interestingly, while gait parameters of the mice were largely
          indistinguishable across genotypes at adolescence, a striking
          difference was seen when the same mice were aged to adulthood
        explanation: >-
          Reports the gait measurement and its change between adolescence and
          adulthood, which is the readout recorded here.
    evidence:
    - reference: PMID:33749590
      reference_title: "Genetic disruption of WASHC4 drives endo-lysosomal dysfunction and cognitive-movement impairments in mice and humans."
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: >-
        We find that SWIPP1019R not only impacts cognition, but also causes
        significant progressive motor deficits in mice.
      explanation: >-
        Supports treating the model as informative for the movement phenotype.
  evidence:
  - reference: PMID:33749590
    reference_title: "Genetic disruption of WASHC4 drives endo-lysosomal dysfunction and cognitive-movement impairments in mice and humans."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      To uncover how dysfunction of endosomal SWIP leads to disease, we generate
      a mouse model of the human WASHC4c.3056C>G mutation.
    explanation: >-
      Establishes that the model carries the human disease allele rather than a
      generic null.

- name: Zebrafish washc4 loss-of-function
  species: Zebrafish
  genotype: washc4 targeted inactivation
  category: Genetic
  publication: PMID:30010465
  description: >-
    Zebrafish study of Washc4 as a VCP interactor. It is a muscle-proteostasis
    experiment, not a neurodevelopmental one, and it is the source of the
    prediction that WASHC4 loss would affect skeletal muscle - a prediction only
    confirmed in patients in 2022.
  genes:
  - preferred_term: WASHC4
    term:
      id: hgnc:29174
      label: WASHC4
  modeled_mechanisms:
  - target: Impaired Autophagic Protein Clearance in Striated Muscle
    relationship: RECAPITULATES
    fidelity: LOW
    model_scale: ORGANISM
    description: >-
      Washc4 inactivation impairs cardiac and skeletal muscle function and
      structure and interferes with autophagy, with ER stress but an intact
      ubiquitin-proteasome system.
    limitations: >-
      Zebrafish, and the study was designed around VCP/p97 myopathy rather than
      around intellectual disability; cardiac involvement of the kind reported
      here has not been described in WASHC4 patients, and the human muscle
      evidence is a single biopsy.
    evidence:
    - reference: PMID:30010465
      reference_title: "Loss of the novel Vcp (valosin containing protein) interactor Washc4 interferes with autophagy-mediated proteostasis in striated muscle and leads to myopathy in vivo."
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: >-
        We found that targeted inactivation of either Vcp or Washc4, led to
        progressive impairment of cardiac and skeletal muscle function,
        structure and cytoarchitecture without interfering with the
        differentiation of both organ systems.
      explanation: >-
        Reports the muscle phenotype produced by loss of the MRT43 gene's
        ortholog.
  evidence:
  - reference: PMID:34599609
    reference_title: "Homozygous WASHC4 variant in two sisters causes a syndromic phenotype defined by dysmorphisms, intellectual disability, profound developmental disorder, and skeletal muscle involvement."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    directness: INDIRECT
    snippet: >-
      Functional studies in a zebrafish model suggested that WASHC4 knockdown
      may also affect skeletal muscles by perturbing protein clearance.
    explanation: >-
      A later human study describing what this zebrafish model established and
      why it was worth testing in patients; cited to record the model's role,
      not as independent muscle evidence.

experimental_models:
- name: WASHC4-deficient patient dermal fibroblasts
  experimental_model_type: PRIMARY_CELL_CULTURE
  publication: PMID:34599609
  description: >-
    Fibroblasts from a patient homozygous for a WASHC4 variant, analysed by
    quantitative proteomics. Human patient material, which is what makes it a
    useful complement to the mouse and zebrafish work.
  organism:
    preferred_term: human
    term:
      id: NCBITaxon:9606
      label: Homo sapiens
  cell_types:
  - preferred_term: fibroblast
    term:
      id: CL:0000057
      label: fibroblast
  modeled_mechanisms:
  - target: Impaired Autophagic Protein Clearance in Striated Muscle
    relationship: MEASURES
    fidelity: LOW
    model_scale: MOLECULAR
    description: >-
      Proteomic profiling of the patient's fibroblasts identified dysregulation
      of proteins relevant to the neuromuscular axis, which is what directed the
      subsequent muscle-biopsy analysis.
    limitations: >-
      Fibroblasts are not muscle. The readout is a proteomic signature in a
      surrogate cell type from one patient, so it indicates rather than
      demonstrates the muscle mechanism.
    evidence:
    - reference: PMID:34599609
      reference_title: "Homozygous WASHC4 variant in two sisters causes a syndromic phenotype defined by dysmorphisms, intellectual disability, profound developmental disorder, and skeletal muscle involvement."
      supports: SUPPORT
      evidence_source: IN_VITRO
      snippet: >-
        Proteomic profiling of fibroblasts of the WASHC4-deficient patient
        revealed dysregulation of proteins relevant for the maintenance of the
        neuromuscular axis.
      explanation: >-
        States what was measured in this model and in which direction the
        interpretation runs.

diagnosis:
- name: Exome sequencing
  description: >-
    All reported families were solved by sequencing. The founding pedigree was
    identified by homozygosity mapping followed by targeted exon enrichment and
    high-throughput sequencing; the later families were ascertained by
    diagnostic exome sequencing. There is no biochemical marker and no
    functional assay in clinical use, so molecular testing is the diagnosis.
  diagnosis_term:
    preferred_term: Whole exome sequencing
    term:
      id: NCIT:C101295
      label: Whole Exome Sequencing
  markers: Biallelic pathogenic or likely pathogenic WASHC4 (KIAA1033) variants.
  evidence:
  - reference: PMID:31953988
    reference_title: "Novel KIAA1033/WASHC4 mutations in three patients with syndromic intellectual disability and a review of the literature."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Here we describe three additional patients (from two unrelated families)
      with syndromic ID due to compound heterozygous KIAA1033 variants
      ascertained by exome sequencing (ES).
    explanation: >-
      Exome sequencing is named as the method by which these diagnoses were
      made.
  - reference: PMID:21498477
    reference_title: "Identification of a novel candidate gene for non-syndromic autosomal recessive intellectual disability: the WASH complex member SWIP."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      In a large consanguineous family with autosomal recessive intellectual
      disability (ARID), we have combined homozygosity mapping, targeted exon
      enrichment and high-throughput sequencing to identify the underlying gene
      defect.
    explanation: >-
      Records the sequencing-based route to the founding diagnosis.

- name: Brain MRI
  description: >-
    Neuroimaging is not diagnostic of MRT43 but is what discloses the
    subependymal heterotopic nodules described in two affected sisters, a
    structural finding that would not be suspected clinically.
  diagnosis_term:
    preferred_term: Magnetic resonance imaging
    term:
      id: NCIT:C16809
      label: Magnetic Resonance Imaging
  evidence:
  - reference: PMID:31953988
    reference_title: "Novel KIAA1033/WASHC4 mutations in three patients with syndromic intellectual disability and a review of the literature."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    directness: INDIRECT
    snippet: >-
      Both had learning disabilities, macrocephaly, dysmorphic features,
      skeletal anomalies, and subependymal heterotopic nodules.
    explanation: >-
      The abstract reports the imaging finding without naming the modality;
      subependymal heterotopic nodules are a neuroimaging diagnosis, so the
      inference that brain imaging was performed is one step removed from what
      the quote states. Graded INDIRECT for that reason.
  notes: >-
    The cited abstract does not state the imaging modality. MRI is the modality
    in which subependymal nodular heterotopia is identified in practice, but
    that is inference, not a sourced statement about these patients.

- name: Genetic counseling
  description: >-
    Confirmation of biallelic WASHC4 variants establishes a 25% sibling
    recurrence risk and identifies both parents as carriers.
  diagnosis_term:
    preferred_term: Genetic counseling
    term:
      id: NCIT:C15240
      label: Genetic Counseling
  evidence:
  - reference: PMID:31953988
    reference_title: "Novel KIAA1033/WASHC4 mutations in three patients with syndromic intellectual disability and a review of the literature."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    directness: INDIRECT
    snippet: >-
      Here we describe three additional patients (from two unrelated families)
      with syndromic ID due to compound heterozygous KIAA1033 variants
      ascertained by exome sequencing (ES).
    explanation: >-
      Establishes carrier status of both parents in each family, which is the
      fact that recurrence-risk counselling rests on. The 25% figure itself is
      the standard recessive expectation and is not asserted by the quote.

- name: Audiological assessment
  description: >-
    Formal hearing assessment, prompted by the bilateral sensorineural hearing
    loss reported in one of the 2020 patients. Applies to case finding for that
    feature; it is not a test for MRT43 itself, which is diagnosed molecularly.
  diagnosis_term:
    preferred_term: audiological assessment
  evidence:
  - reference: PMID:31953988
    reference_title: "Novel KIAA1033/WASHC4 mutations in three patients with syndromic intellectual disability and a review of the literature."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    directness: INDIRECT
    snippet: >-
      In addition, the younger sibling had a congenital absence of the right
      internal carotid and bilateral sensorineural hearing loss.
    explanation: >-
      Establishes the finding that makes audiological assessment relevant. The
      source reports the hearing loss but does not describe the assessment
      pathway, so this is indirect support for the diagnostic entry rather than
      a statement that audiology is part of a workup.
  notes: >-
    No NCIT clinical-action term for audiological assessment is reachable from
    NCIT:C25218, so this entry carries a free-text preferred_term only, matching
    the treatment entry in Congenital_Heart_Defects_and_Skeletal_Malformations_Syndrome.
    NCIT:C85857 Evoked Response Audiometry is reachable and would validate, but
    the source does not say which test was performed, and binding a specific
    audiometric modality the report never names would manufacture specificity
    the evidence does not carry.

treatments:
- name: Developmental and Educational Intervention
  description: >-
    Special education and developmental support for the intellectual disability.
    This is generic intellectual-disability management applied to MRT43; no
    study has assessed any intervention in WASHC4-related disease, and none is
    cited here because none exists.
  treatment_term:
    preferred_term: developmental and educational support for intellectual disability
    term:
      id: NCIT:C15315
      label: Rehabilitation
  therapeutic_modality: BEHAVIORAL
  target_phenotypes:
  - preferred_term: Intellectual disability
    term:
      id: HP:0001249
      label: Intellectual disability
  notes: >-
    Deliberately uncited. Searches of the four primary WASHC4 reports and of
    PubMed for WASHC4/KIAA1033 treatment or management returned no
    disease-specific therapeutic study, guideline, or trial, and no GeneReviews
    chapter exists for this entity. Rather than attach a quote from an unrelated
    intellectual-disability paper, the claim is left as an unevidenced statement
    of ordinary supportive practice. The binding was NCIT:C15302 Physical
    Therapy, which named only one strand of what this entry described; the
    speech-language and physical strands are now separate treatments and this
    entry is bound to the generic rehabilitative action, with the specificity
    carried in preferred_term.

- name: Speech and Language Therapy
  description: >-
    Speech and language intervention for the delayed language development and
    poor expressive speech, which are among the most consistently reported
    features. As with the other supportive measures, no WASHC4-specific study
    has assessed it.
  treatment_term:
    preferred_term: speech and language therapy
    term:
      id: NCIT:C159273
      label: Speech Language Therapy
  therapeutic_modality: BEHAVIORAL
  target_phenotypes:
  - preferred_term: Delayed speech and language development
    term:
      id: HP:0000750
      label: Delayed speech and language development
  notes: >-
    Deliberately uncited, for the same reason as the developmental-intervention
    entry. Split out of that entry so the NCIT action term names what is
    actually being delivered rather than a single adjacent modality.

- name: Physical Therapy
  description: >-
    Physical therapy for the motor signs - fine motor difficulty, dysmetria,
    dysdiadochokinesis - and for the skeletal and muscle involvement. Ordinary
    supportive practice; no WASHC4-specific study has assessed it.
  treatment_term:
    preferred_term: physical therapy
    term:
      id: NCIT:C15302
      label: Physical Therapy
  therapeutic_modality: BEHAVIORAL
  target_phenotypes:
  - preferred_term: Movement abnormality
    term:
      id: HP:0100022
      label: Abnormality of movement
  - preferred_term: Myopathy
    term:
      id: HP:0003198
      label: Myopathy
  notes: >-
    Deliberately uncited, for the same reason as the developmental-intervention
    entry.

- name: Occupational Therapy
  description: >-
    Occupational therapy for the fine motor difficulty and for adaptive and
    daily-living skills. Ordinary supportive practice; no WASHC4-specific study
    has assessed it.
  treatment_term:
    preferred_term: occupational therapy
    term:
      id: NCIT:C121351
      label: Occupational Therapy
  therapeutic_modality: BEHAVIORAL
  target_phenotypes:
  - preferred_term: Delayed fine motor development
    term:
      id: HP:0010862
      label: Delayed fine motor development
  notes: >-
    Deliberately uncited, for the same reason as the developmental-intervention
    entry. Recorded separately from physical therapy because treatment_term is
    single-valued and the two are distinct NCIT clinical actions.

- name: Audiological Management
  description: >-
    Assessment and amplification for the bilateral sensorineural hearing loss
    reported in one patient. Applies only to the patient subset with hearing
    loss.
  treatment_term:
    preferred_term: Rehabilitation
    term:
      id: NCIT:C15315
      label: Rehabilitation
  therapeutic_modality: BEHAVIORAL
  target_phenotypes:
  - preferred_term: Bilateral sensorineural hearing loss
    term:
      id: HP:0000407
      label: Sensorineural hearing impairment
  notes: >-
    Deliberately uncited, for the same reason as the developmental-intervention
    entry: the hearing loss is documented (PMID:31953988) but its management in
    this disorder is not described anywhere in the WASHC4 literature.

discussions:
- discussion_id: mrt43_nonsyndromic_label_unstable
  kind: CONTROVERSY
  status: OPEN
  prompt: >-
    Is MRT43 a non-syndromic intellectual disability, as its MONDO placement and
    its founding report say, or a syndromic one, as every subsequent report says?
  attaches_to:
  - phenotypes#Dysmorphic Facial Features
  - phenotypes#Skeletal Muscle Involvement
  rationale: >-
    MONDO:0014354 is a child of MONDO:0019502, autosomal recessive NON-syndromic
    intellectual disability, and the 2011 title says "non-syndromic". The 2020
    paper's own title says "syndromic intellectual disability", the 2022 title
    says "a syndromic phenotype", and between them they report dysmorphism,
    skeletal anomalies, subependymal nodular heterotopia, hearing loss, an
    absent internal carotid artery and skeletal muscle involvement. This entry
    curates the phenotype the later reports describe while keeping the MONDO
    binding, because the identifier is what the community indexes against; the
    disagreement is recorded here rather than resolved by silently recategorising
    the disorder. This is the same instability the class-level entry
    Autosomal_Recessive_Non-Syndromic_Intellectual_Disability already flags for
    NSUN2, MAN1B1 and ADAT3 - MRT43 is another instance of it, not a new
    phenomenon.
  evidence:
  - reference: PMID:31953988
    reference_title: "Novel KIAA1033/WASHC4 mutations in three patients with syndromic intellectual disability and a review of the literature."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      We conclude that KIAA1033 is responsible for a heterogeneous ARID
      phenotype, and additional description will be needed to refine the
      clinical phenotype.
    explanation: >-
      The authors themselves decline to settle the phenotype, which is the
      unresolved state this discussion records.

- discussion_id: mrt43_static_or_degenerative
  kind: KNOWLEDGE_GAP
  status: OPEN
  prompt: >-
    Is MRT43 a static developmental encephalopathy, or does the endo-lysosomal
    defect drive a slowly progressive neurodegenerative process in patients?
  attaches_to:
  - pathophysiology#Neuronal Endo-Lysosomal Dysfunction
  - phenotypes#Movement Impairment
  rationale: >-
    The MRT series is conventionally treated as static, and developmental
    regression is taken to argue against the diagnosis. The knock-in mouse says
    otherwise for this gene: lipofuscin accumulation, progressive caspase-3
    activation, and motor decline that worsens between adolescence and
    adulthood. The human evidence is a retrospective chart review that found
    movement deficits, not a longitudinal study that found progression. No
    patient has been followed prospectively, and no human neuropathology exists.
    Resolving this changes surveillance - whether these patients need serial
    motor assessment - and it changes whether MRT43 should be described as a
    neurodevelopmental or a neurodegenerative disorder.
  evidence:
  - reference: PMID:33749590
    reference_title: "Genetic disruption of WASHC4 drives endo-lysosomal dysfunction and cognitive-movement impairments in mice and humans."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      Cellular and histological analyses confirm that SWIPP1019R results in
      endo-lysosomal disruption and uncover indicators of neurodegeneration.
    explanation: >-
      The neurodegenerative indicators that make the question live are
      established in the mouse; the gap is that they have not been sought in
      patients.

- discussion_id: mrt43_no_therapeutic_evidence
  kind: KNOWLEDGE_GAP
  status: OPEN
  prompt: >-
    Is there any evidence bearing on management of MRT43, beyond generic
    intellectual-disability supportive care?
  attaches_to:
  - treatments#
  rationale: >-
    No treatment study, management guideline, natural-history study, clinical
    trial or GeneReviews chapter exists for WASHC4-related disease. The two
    treatment entries here are ordinary supportive practice and carry no
    evidence for that reason, which is recorded explicitly rather than papered
    over with a quotation from an unrelated intellectual-disability paper. With
    fewer than fifteen reported patients this is a consequence of cohort size,
    not of neglect, and the first thing needed is a natural-history description
    rather than an intervention.
  evidence:
  - reference: PMID:31953988
    reference_title: "Novel KIAA1033/WASHC4 mutations in three patients with syndromic intellectual disability and a review of the literature."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Since then, no other cases of KIAA1033 variants have been reported.
    explanation: >-
      Supports the cohort-size explanation: nine years after the founding report
      the total published series was still one family.

differential_diagnoses:
- name: Ritscher-Schinzel (3C) syndrome and SPG8 (WASHC5/strumpellin)
  description: >-
    WASHC5, formerly KIAA0196, encodes strumpellin, a different subunit of the
    same WASH complex. Biallelic WASHC5 variants cause Ritscher-Schinzel / 3C
    syndrome with cranio-cerebello-cardiac malformations; heterozygous WASHC5
    variants cause hereditary spastic paraplegia type 8. Neither is MRT43, and
    the similarity of the gene symbols and the shared complex make this the most
    likely confusion in the WASHC4 literature. The distinguishing features are
    the gene, the inheritance pattern for SPG8, and the malformation and
    spastic-paraparesis phenotypes, none of which characterise MRT43.
  distinguishing_features:
  - Caused by WASHC5/KIAA0196, not WASHC4/KIAA1033
  - 3C syndrome features cerebellar and cardiac malformations not reported in MRT43
  - SPG8 is dominantly inherited spastic paraplegia, not recessive intellectual disability
  evidence:
  - reference: PMID:31953988
    reference_title: "Novel KIAA1033/WASHC4 mutations in three patients with syndromic intellectual disability and a review of the literature."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Another member of the WASH complex, KIAA0196/WASHC5, has already been
      implicated in ARID with brain and cardiac malformations, under the
      designation of 3C or Ritscher-Schinzel syndrome (MIM#20210).
    explanation: >-
      The WASHC4 paper itself distinguishes its gene from the WASHC5 disorder,
      which is the distinction this entry records.
  - reference: PMID:20498093
    reference_title: "WASH and WAVE actin regulators of the Wiskott-Aldrich syndrome protein (WASP) family are controlled by analogous structurally related complexes."
    supports: SUPPORT
    evidence_source: IN_VITRO
    directness: INDIRECT
    snippet: >-
      Strumpellin is mutated in the human disease hereditary spastic paraplegia,
      and its link to WASH suggests that misregulation of actin dynamics on
      endosomes may play a role in this disorder.
    explanation: >-
      Establishes the second, dominant strumpellin disorder that must not be
      conflated with MRT43. The quote is about strumpellin/WASHC5 in a
      biochemical study of the complex, not about WASHC4 patients, hence
      INDIRECT.

- name: WASHC3-related short stature and neurodevelopmental syndrome
  description: >-
    WASHC3/CCDC53 is a third subunit of the same pentamer. Variants in it were
    reported in 2025 to cause short stature, variable neurodevelopmental
    abnormalities and distinctive facial dysmorphism - a phenotype that overlaps
    MRT43 closely enough to be a real diagnostic and curation confusion, since
    short stature, developmental abnormality and dysmorphism are exactly the
    MRT43 triad. The distinction is the gene, and that one reported WASHC3
    family carries a de novo dominant allele rather than biallelic variants.
  distinguishing_features:
  - Caused by WASHC3/CCDC53, not WASHC4/KIAA1033
  - Includes a de novo dominant missense family, so inheritance is not uniformly recessive
  - Short stature is attributed to impaired PTH1R endosomal trafficking in growth plate chondrocytes, a mechanism not demonstrated for WASHC4
  evidence:
  - reference: PMID:40129681
    reference_title: "Variants in WASHC3, a component of the WASH complex, cause short stature, variable neurodevelopmental abnormalities, and distinctive facial dysmorphism."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      RESULTS: Exome sequencing identified variants in WASHC3, a component of
      the WASH complex.
    explanation: >-
      Establishes that a second WASH-complex subunit gene causes an overlapping
      human phenotype, which is the confusion this differential guards against.
  - reference: PMID:40129681
    reference_title: "Variants in WASHC3, a component of the WASH complex, cause short stature, variable neurodevelopmental abnormalities, and distinctive facial dysmorphism."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      In the first family, a de-novo-dominant missense variant (p.L69F) impaired
      WASHC3 participation in the WASH complex, altered PTH1R endosomal
      trafficking, diminished PTH1R signaling, and affected growth plate
      chondrocyte hypertrophic differentiation, providing a likely explanation
      for the short stature.
    explanation: >-
      Names the dominant inheritance and the chondrocyte mechanism that separate
      that disorder from MRT43.

- name: CCDC22-related attenuated 3C/Ritscher-Schinzel syndrome
  description: >-
    CCDC22 is a subunit of the CCC complex, which works together with the WASH
    complex on the same endosomal recycling step. Biallelic CCDC22 variants
    cause 3C/Ritscher-Schinzel syndrome, and a 2025 report describes an
    attenuated form without the cardiac or neuroanatomical malformations - a
    neurodevelopmental presentation that overlaps MRT43 more closely than the
    classical malformation syndrome does. The distinction is the gene and the
    complex, not the phenotype.
  distinguishing_features:
  - Caused by CCDC22, a CCC-complex subunit, not by WASHC4 in the WASH complex
  - The classical form carries cranio-cerebello-cardiac malformations absent from MRT43
  - The attenuated form is defined by the absence of those malformations, which is what makes it the harder differential
  evidence:
  - reference: PMID:40448120
    reference_title: "CCDC22 mutations that impair COMMD binding cause attenuated 3C/Ritscher-Schinzel syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Here, we report a new CCDC22 missense mutation, p.E208K, that results in
      attenuated 3 C syndrome, without cardiac or neuroanatomical abnormalities.
    explanation: >-
      Establishes the attenuated, malformation-free CCDC22 presentation that
      this differential guards against.
  - reference: PMID:40448120
    reference_title: "CCDC22 mutations that impair COMMD binding cause attenuated 3C/Ritscher-Schinzel syndrome."
    supports: SUPPORT
    evidence_source: IN_VITRO
    directness: INDIRECT
    snippet: >-
      CCC interacts with Retriever, a trimeric cargo recognition complex
      comprising VPS35L, VPS26C, and VPS29, and works closely with the WASH
      complex, a crucial regulator of branched actin polymerization at endosomal
      membranes.
    explanation: >-
      States the functional relationship between the CCC complex and the WASH
      complex that WASHC4 belongs to, which is why the two disorders converge
      phenotypically. The quote is from the biochemical framing of the paper
      rather than from its patient description, hence INDIRECT.

notes: >-
  Scope and modelling decisions. (1) LUMP/SPLIT: curated as a standalone Disease
  entry rather than as a has_subtypes row on the class-level entry
  Autosomal_Recessive_Non-Syndromic_Intellectual_Disability. MONDO:0014354 is a
  leaf - no descendants - with a single causal-gene assertion (RO:0004003
  HGNC:29174), which is the gene-defined Mendelian leaf signature the repository
  treats as an entry. The class-level entry's own notes state that its
  has_subtypes rows are "exemplars chosen to span the mechanistic theme set...
  not an exhaustive enumeration", that WASHC4 is not among them, and that
  modelling the class as a Grouping is blocked because "a Grouping requires its
  members to exist as separate Disease entries, which the MRT series does not
  yet". This entry is one such member. The substantive reason, beyond
  bookkeeping, is that MRT43 now carries content a class-level node cannot hold:
  a worked molecular mechanism, an allele-specific knock-in mouse, and a
  phenotype that has migrated out of the non-syndromic category. (2) The entry
  does NOT assert pathway convergence with the other AR-ID trafficking genes.
  The class entry lists WASHC4 alongside TRAPPC9, TRAPPC6B, TBC1D23 and CC2D1A
  under "vesicle trafficking with NF-kB signalling" and states explicitly that
  these are "post-hoc organising themes, not a claim of pathway convergence".
  Nothing here contradicts that: no NF-kB claim is made for WASHC4, and no
  shared mechanism with those genes is curated, because none of the sources
  makes one. (3) The retromer framing is deliberately qualified. The common
  shorthand is that the WASH complex reaches the endosome downstream of
  retromer, via FAM21-VPS35. PMID:36995008 shows that SWIP - the MRT43 gene
  product itself - provides a second, retromer-INDEPENDENT anchor through
  phosphoinositide binding. The pathophysiology chain therefore has a separate
  node for the loss of that anchor, and the entry does not describe MRT43 as a
  retromer disorder. (4) NAMED ENTITY CONFUSION guard: WASHC5/strumpellin
  (Ritscher-Schinzel/3C syndrome, SPG8), VPS35 (Parkinson disease) and the
  broader WASH/retromer cell-biology literature are adjacent to this gene and
  are NOT this disease. WASHC5 is recorded under differential_diagnoses for that
  reason. No VPS35 or WASHC5 finding is curated as MRT43 evidence, and the
  cell-biology citations used here (PMID:20498093, PMID:36995008) are cited
  specifically for statements about SWIP/KIAA1033 or about the complex that
  contains it. (5) No conforms_to. There is no endosomal-sorting, retromer, or
  WASH-complex module in kb/modules/ (grep for "retromer" and "WASH complex"
  across the module directory returns nothing), and conforming this entry to an
  autophagy or proteostasis module would assert a relationship the sources do
  not make - PMID:30010465 specifically found the proteasome arm intact. A
  future endosomal-sorting module would be the right conformance target. (6) No
  GeneReviews chapter exists (PubMed "WASHC4 GeneReviews[All Fields]" returns
  zero results), so the GeneReviews phenotype baseline step could not be
  applied; the phenotype set is built from the four primary reports. (7)
  Prevalence carries no numeric rate. Nothing has been published beyond a case
  count, so measure_type is CASES_IN_LITERATURE with the qualitative
  ULTRA_RARE band and no rate_per_100000. (8) Macrocephaly and microcephaly are
  curated as separate phenotypes rather than as one "abnormal head
  circumference" node, because they are opposite findings in different patients
  within a single report, not a variable trait with an agreed direction. (9)
  Treatments carry no evidence, by decision rather than omission; see the
  mrt43_no_therapeutic_evidence discussion and the per-treatment notes. (10) The
  medRxiv preprint PMID:38712155, which reports a rare-variant association of
  WASHC4 with "abnormality of speech or vocalization" in a paediatric
  speech-and-language cohort, was read and deliberately NOT cited: it is a
  cohort-level burden association in a broad EMR population, not a statement
  about MRT43 patients, and the language phenotype is already directly evidenced
  by PMID:34599609. (11) Deep research used the claude_code provider;
  falcon was unavailable (HTTP 402) in this environment. Every PMID cited here
  was fetched independently with just fetch-reference and every snippet verified
  against the cached record. (12) The deep-research report attributes the
  founding MRT43 description to Najmabadi et al., Nature 2011 (PMID:21937992,
  "Deep sequencing reveals 50 novel genes for recessive cognitive disorders").
  That is wrong, and this entry does not follow it. The founding WASHC4 report
  is Ropers et al., Hum Mol Genet 2011 (PMID:21498477), which describes the
  consanguineous pedigree, the SWIP variant and the complex destabilisation, and
  which the eLife mouse paper cites as the source of the p.Pro1019Arg allele it
  models. PMID:21937992 is therefore not cited here at all, because no verified
  quote from it names KIAA1033/WASHC4.

  (13) REVIEW ROUND 1, declined items. The brain location UBERON:0000955 on the
  Neuronal Endo-Lysosomal Dysfunction node is left broad rather than narrowed to
  UBERON:0001384 primary motor cortex. The mouse work localises the
  lipofuscin and cleaved-caspase-3 findings to motor cortex, but the
  endo-lysosomal phenotype itself is reported in cultured neurons and in vivo
  without that restriction, and the human data are a chart review with no tissue
  at all. Narrowing the node would assert a regional specificity for the
  mechanism that the cited evidence does not carry. The audiological entry was
  added to diagnosis rather than bound to NCIT:C85857 Evoked Response
  Audiometry, for the reason recorded on that entry.

  (14) REVIEW ROUND 1, corrections to the review. Two of the seven titles in the
  reviewer's fill table do not match the reference cache, and one cited PMID is
  absent from the table. Every reference_title in this file was copied from the
  cache frontmatter, which is the repository's authority for a title, so this
  entry does not follow the table where it diverges: PMID:20498093 is "WASH and
  WAVE actin regulators of the Wiskott-Aldrich syndrome protein (WASP) family
  are controlled by analogous structurally related complexes", not the
  Hermansky-Pudlak paper; PMID:40129681 is "Variants in WASHC3, a component of
  the WASH complex, cause short stature, variable neurodevelopmental
  abnormalities, and distinctive facial dysmorphism", not "Bi-allelic variants
  in WASHC3 cause a syndromic neurodevelopmental disorder with short stature";
  and PMID:30010465, cited twice here, is not in the table at all. Separately,
  the review proposed HP:0011933 for the absent internal carotid artery. That
  CURIE resolves to Elongated superior cerebellar peduncle, so it is not used;
  see the note on that phenotype for what was bound instead and why.

📚

References & Deep Research

References

9

PMID:21498477

Identification of a novel candidate gene for non-syndromic autosomal recessive intellectual disability: the WASH complex member SWIP.

No top-level findings curated for this source.

PMID:31953988

Novel KIAA1033/WASHC4 mutations in three patients with syndromic intellectual disability and a review of the literature.

No top-level findings curated for this source.

PMID:34599609

Homozygous WASHC4 variant in two sisters causes a syndromic phenotype defined by dysmorphisms, intellectual disability, profound developmental disorder, and skeletal muscle involvement.

No top-level findings curated for this source.

PMID:33749590

Genetic disruption of WASHC4 drives endo-lysosomal dysfunction and cognitive-movement impairments in mice and humans.

No top-level findings curated for this source.

PMID:20498093

WASH and WAVE actin regulators of the Wiskott-Aldrich syndrome protein (WASP) family are controlled by analogous structurally related complexes.

No top-level findings curated for this source.

PMID:30010465

Loss of the novel Vcp (valosin containing protein) interactor Washc4 interferes with autophagy-mediated proteostasis in striated muscle and leads to myopathy in vivo.

No top-level findings curated for this source.

PMID:36995008

SWIP mediates retromer-independent membrane recruitment of the WASH complex.

No top-level findings curated for this source.

PMID:40129681

Variants in WASHC3, a component of the WASH complex, cause short stature, variable neurodevelopmental abnormalities, and distinctive facial dysmorphism.

No top-level findings curated for this source.

PMID:40448120

CCDC22 mutations that impair COMMD binding cause attenuated 3C/Ritscher-Schinzel syndrome.

No top-level findings curated for this source.

Deep Research

1

Deep research results are used as seeds for research; they do not undergo the same validation as the main records and may contain errors. How we use deep research.

Evaluations and curation notes (2)

Record notes

Scope and modelling decisions. (1) LUMP/SPLIT: curated as a standalone Disease entry rather than as a has_subtypes row on the class-level entry Autosomal_Recessive_Non-Syndromic_Intellectual_Disability. MONDO:0014354 is a leaf - no descendants - with a single causal-gene assertion (RO:0004003 HGNC:29174), which is the gene-defined Mendelian leaf signature the repository treats as an entry. The class-level entry's own notes state that its has_subtypes rows are "exemplars chosen to span the mechanistic theme set... not an exhaustive enumeration", that WASHC4 is not among them, and that modelling the class as a Grouping is blocked because "a Grouping requires its members to exist as separate Disease entries, which the MRT series does not yet". This entry is one such member. The substantive reason, beyond bookkeeping, is that MRT43 now carries content a class-level node cannot hold: a worked molecular mechanism, an allele-specific knock-in mouse, and a phenotype that has migrated out of the non-syndromic category. (2) The entry does NOT assert pathway convergence with the other AR-ID trafficking genes. The class entry lists WASHC4 alongside TRAPPC9, TRAPPC6B, TBC1D23 and CC2D1A under "vesicle trafficking with NF-kB signalling" and states explicitly that these are "post-hoc organising themes, not a claim of pathway convergence". Nothing here contradicts that: no NF-kB claim is made for WASHC4, and no shared mechanism with those genes is curated, because none of the sources makes one. (3) The retromer framing is deliberately qualified. The common shorthand is that the WASH complex reaches the endosome downstream of retromer, via FAM21-VPS35. PMID:36995008 shows that SWIP - the MRT43 gene product itself - provides a second, retromer-INDEPENDENT anchor through phosphoinositide binding. The pathophysiology chain therefore has a separate node for the loss of that anchor, and the entry does not describe MRT43 as a retromer disorder. (4) NAMED ENTITY CONFUSION guard: WASHC5/strumpellin (Ritscher-Schinzel/3C syndrome, SPG8), VPS35 (Parkinson disease) and the broader WASH/retromer cell-biology literature are adjacent to this gene and are NOT this disease. WASHC5 is recorded under differential_diagnoses for that reason. No VPS35 or WASHC5 finding is curated as MRT43 evidence, and the cell-biology citations used here (PMID:20498093, PMID:36995008) are cited specifically for statements about SWIP/KIAA1033 or about the complex that contains it. (5) No conforms_to. There is no endosomal-sorting, retromer, or WASH-complex module in kb/modules/ (grep for "retromer" and "WASH complex" across the module directory returns nothing), and conforming this entry to an autophagy or proteostasis module would assert a relationship the sources do not make - PMID:30010465 specifically found the proteasome arm intact. A future endosomal-sorting module would be the right conformance target. (6) No GeneReviews chapter exists (PubMed "WASHC4 GeneReviews[All Fields]" returns zero results), so the GeneReviews phenotype baseline step could not be applied; the phenotype set is built from the four primary reports. (7) Prevalence carries no numeric rate. Nothing has been published beyond a case count, so measure_type is CASES_IN_LITERATURE with the qualitative ULTRA_RARE band and no rate_per_100000. (8) Macrocephaly and microcephaly are curated as separate phenotypes rather than as one "abnormal head circumference" node, because they are opposite findings in different patients within a single report, not a variable trait with an agreed direction. (9) Treatments carry no evidence, by decision rather than omission; see the mrt43_no_therapeutic_evidence discussion and the per-treatment notes. (10) The medRxiv preprint PMID:38712155, which reports a rare-variant association of WASHC4 with "abnormality of speech or vocalization" in a paediatric speech-and-language cohort, was read and deliberately NOT cited: it is a cohort-level burden association in a broad EMR population, not a statement about MRT43 patients, and the language phenotype is already directly evidenced by PMID:34599609. (11) Deep research used the claude_code provider; falcon was unavailable (HTTP 402) in this environment. Every PMID cited here was fetched independently with just fetch-reference and every snippet verified against the cached record. (12) The deep-research report attributes the founding MRT43 description to Najmabadi et al., Nature 2011 (PMID:21937992, "Deep sequencing reveals 50 novel genes for recessive cognitive disorders"). That is wrong, and this entry does not follow it. The founding WASHC4 report is Ropers et al., Hum Mol Genet 2011 (PMID:21498477), which describes the consanguineous pedigree, the SWIP variant and the complex destabilisation, and which the eLife mouse paper cites as the source of the p.Pro1019Arg allele it models. PMID:21937992 is therefore not cited here at all, because no verified quote from it names KIAA1033/WASHC4. (13) REVIEW ROUND 1, declined items. The brain location UBERON:0000955 on the Neuronal Endo-Lysosomal Dysfunction node is left broad rather than narrowed to UBERON:0001384 primary motor cortex. The mouse work localises the lipofuscin and cleaved-caspase-3 findings to motor cortex, but the endo-lysosomal phenotype itself is reported in cultured neurons and in vivo without that restriction, and the human data are a chart review with no tissue at all. Narrowing the node would assert a regional specificity for the mechanism that the cited evidence does not carry. The audiological entry was added to diagnosis rather than bound to NCIT:C85857 Evoked Response Audiometry, for the reason recorded on that entry. (14) REVIEW ROUND 1, corrections to the review. Two of the seven titles in the reviewer's fill table do not match the reference cache, and one cited PMID is absent from the table. Every reference_title in this file was copied from the cache frontmatter, which is the repository's authority for a title, so this entry does not follow the table where it diverges: PMID:20498093 is "WASH and WAVE actin regulators of the Wiskott-Aldrich syndrome protein (WASP) family are controlled by analogous structurally related complexes", not the Hermansky-Pudlak paper; PMID:40129681 is "Variants in WASHC3, a component of the WASH complex, cause short stature, variable neurodevelopmental abnormalities, and distinctive facial dysmorphism", not "Bi-allelic variants in WASHC3 cause a syndromic neurodevelopmental disorder with short stature"; and PMID:30010465, cited twice here, is not in the table at all. Separately, the review proposed HP:0011933 for the absent internal carotid artery. That CURIE resolves to Elongated superior cerebellar peduncle, so it is not used; see the note on that phenotype for what was bound instead and why.

Create: Intellectual_Disability_Autosomal_Recessive_43 · 2026-09-07T22:34:20Z · View source

De novo creation of the MRT43 (WASHC4/KIAA1033/SWIP) entry from the stub stubs/Intellectual_Disability_Autosomal_Recessive_43.yaml. LUMP/SPLIT: curated as a standalone Disease rather than a has_subtypes row on the class-level entry Autosomal_Recessive_Non-Syndromic_Intellectual_Disability. MONDO:0014354 is a leaf (no descendants, checked against the local MONDO SQLite) with a single causal-gene assertion RO:0004003 HGNC:29174. The class-level entry's own notes declare its has_subtypes rows to be non-exhaustive exemplars (WASHC4 is not among them) and state that a Grouping treatment is blocked until MRT-series members exist as separate Disease entries. The entry does NOT assert pathway convergence with TRAPPC9/TRAPPC6B/TBC1D23/CC2D1A, and makes no NF-kB claim for WASHC4, so it does not contradict the class entry's 'post-hoc organising themes, not a claim of pathway convergence' framing. DEEP RESEARCH: provider claude_code (falcon returns HTTP 402 in this environment; no substitution was made by hand). Report research/Intellectual_Disability_Autosomal_Recessive_43-deep-research-claude_code.md, 319s, 16 web searches. reference_validation: 7/7 resolved, 0 unresolved, confabulation_rate 0.0, quotes 1/1 valid, 6/7 on topic. term_validation: needs_review true, driven by a single mislabelled_terms entry for MONDO:0014354 whose reported labels are the parsing artifacts 'MONDO' and 'EBI OLS'; no unresolved_terms, 0 not_found, 0 obsolete. just preflight-dr against MONDO:0014354 returned PASS (WASHC4 mentioned 37 times; OMIM 615817 matches). CORRECTION TO THE DR REPORT: the report attributes the founding MRT43 description to Najmabadi et al., Nature 2011 (PMID:21937992). That is wrong. The founding WASHC4 report is Ropers et al., Hum Mol Genet 2011 (PMID:21498477) - the paper that describes the consanguineous pedigree, the SWIP variant and the WASH-complex destabilisation, and which the eLife knock-in mouse paper cites as the source of the p.Pro1019Arg allele. PMID:21937992 is not cited in the entry, since no verified quote from it names KIAA1033/WASHC4. This correction is recorded in the entry notes. NAMED ENTITY CONFUSION: WASHC5/strumpellin (Ritscher-Schinzel/3C, SPG8), WASHC3 (2025 short-stature/dysmorphism syndrome, PMID:40129681), CCDC22, and VPS35/retromer are all adjacent to this gene. WASHC5 and WASHC3 are curated under differential_diagnoses rather than being allowed to leak into the phenotype set. Cell-biology citations (PMID:20498093, PMID:36995008) are used only for statements about SWIP/KIAA1033 or about the complex containing it. RETROMER FRAMING: the entry deliberately does not describe MRT43 as a retromer disorder. PMID:36995008 shows SWIP itself provides a retromer-INDEPENDENT membrane anchor via phosphoinositide binding, so the chain carries a separate node for loss of that anchor alongside the FAM21-VPS35 route. EVIDENCE: 9 references, all fetched with just fetch-reference and all snippets extracted programmatically from the cached records. One eLife sentence was dropped because the cached full text renders it with a missing space ('SWIPP1019Rresults'); a different, clean sentence from the same paper was substituted rather than quoting the mangled form. treatments carry no evidence by decision - no treatment study, guideline, trial or GeneReviews chapter exists for WASHC4 - recorded in the mrt43_no_therapeutic_evidence discussion and in per-treatment notes. The medRxiv preprint PMID:38712155 (WASHC4 rare-variant association with abnormality of speech or vocalization) was read and deliberately not cited: it is a cohort burden association, not a statement about MRT43 patients. VALIDATION: just validate PASS; just validate-terms PASS; just count-verified-snippets 60/60; check-duplicate-keys, check-entity-refs, check-causal-targets, check-qualifier-terms, check-enum-values all OK; just validate-disorders PASS with 60/60 snippets verified. just qc was not run (exceeds the tool timeout).

Claude Code ▸

1. Disease Information

claude-haiku-4-5-20251001, claude-sonnet-5 14 citations 2026-09-07T22:23:00.829944

1. Disease Information

Overview. Intellectual Disability, Autosomal Recessive 43 (also designated Intellectual Developmental Disorder, Autosomal Recessive 43; MRT43) is a rare, genetically defined, non-syndromic-to-mildly-syndromic form of inherited intellectual disability caused by biallelic (homozygous or compound heterozygous) loss-of-function or destabilizing missense variants in WASHC4 (formerly KIAA1033), a subunit of the pentameric WASH regulatory complex that controls actin-driven endosomal membrane trafficking. It was first delineated in 2011 as one of the novel candidate genes emerging from a large homozygosity-mapping/exome-sequencing survey of consanguineous families with autosomal-recessive cognitive disorders (Najmabadi et al., Nature, 2011, PMID:21937992), in which a large consanguineous Omani kindred with seven affected individuals segregated a homozygous KIAA1033 missense variant. Subsequent case reports (Assoum et al. 2020, PMID:31953988; Gangfuß et al. 2022, PMID:34599609) have broadened the phenotype beyond the original "non-syndromic" description to include dysmorphism, macrocephaly, skeletal anomalies, and (most recently) skeletal-muscle involvement — indicating the entry is better framed as a variably syndromic ARID (autosomal-recessive intellectual disability) rather than a purely non-syndromic one.

Key identifiers | Resource | Identifier | |---|---| | MONDO | MONDO:0014354 | | OMIM phenotype | #615817 — INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 43; MRT43 | | OMIM gene | *615748 — WASH COMPLEX, SUBUNIT 4; WASHC4 | | Gene symbol / former symbol | WASHC4 / KIAA1033 | | HGNC | HGNC:29174 | | NCBI Gene | 23325 | | Chromosome location | 12q23.3 (GRCh38: chr12:105,107,324–105,169,134) | | Orphanet | Falls under ORPHA:88616, Autosomal recessive non-syndromic intellectual disability (gene-level entry, no dedicated ORPHA number for MRT43 specifically) | | Mouse ortholog | Washc4, MGI:2441787 | | Protein alias | SWIP (Strumpellin and WASH-Interacting Protein) |

Synonyms/alternative names: Autosomal Recessive Mental Retardation-43; MRT43; ARID due to WASHC4 deficiency; KIAA1033-related intellectual disability. Not to be confused with the autosomal dominant MRD43 (HIVEP2-related, OMIM #616977) or with "Alwadei syndrome"/MRT61 (RUSC2-related), which are distinct entities that surface in searches on similar terms.

Evidence basis. The knowledge base for this entry is drawn from aggregated disease-level literature (case series and functional studies), not an EHR/registry cohort — fewer than a dozen affected individuals across four published kindreds/case reports have been reported to date, so most quantitative claims below (e.g., "short stature," "IQ 35–50") describe the founder family rather than an established population distribution.

2. Etiology

Disease causal factor: Purely genetic/monogenic. Biallelic pathogenic variation in WASHC4 is both necessary and sufficient to cause the phenotype reported to date; no environmental, infectious, or polygenic contributors have been described.

Genetic risk factors - The founder variant: c.3056C>G (p.Pro1019Arg) in exon 29, homozygous in the original large consanguineous Omani family (7 affected/PMID:21937992, further mechanistically characterized in PMID:33749590). P1019R falls in a region of SWIP thought to be critical for binding to the WASH-complex subunit Strumpellin (WASHC5/KIAA0196). - Assoum et al. 2020 (PMID:31953988) reported novel compound heterozygous variants in two unrelated families: p.(Gln442) [nonsense/truncating] with p.(Asp1048Gly) [missense] in two sisters, and p.(Lys1079Arg) with p.(His503Arg) [both missense] in a third, unrelated adult patient. - Gangfuß et al. 2022 (PMID:34599609) reported a homozygous WASHC4 variant in two further sisters with an expanded syndromic/skeletal-muscle phenotype. - Consanguinity is a major risk factor for exposing this recessive allele; all reported kindreds to date have been consanguineous or from a founder-enriched (Omani) population, consistent with the general enrichment of rare autosomal-recessive ID genes in consanguineous Middle Eastern/Gulf cohorts (see Khan et al. 2016, Ann Hum Genet*, PMID review context found via search but not independently fetched here — flagged as unverified secondary characterization). - WASHC4 is intolerant of complete loss of function at the organismal level (see §15, Model Organisms): homozygous null mice are embryonic lethal, implying that reported human patients likely carry hypomorphic/partial-loss-of-function alleles (missense destabilizing variants or truncations sparing residual function) rather than complete nulls — this is an inference from the mouse data, not directly demonstrated in humans.

Environmental risk factors: None reported; this is a pure Mendelian recessive disorder.

Protective factors: None described in the literature.

Gene–environment interaction: Not applicable / not studied.

3. Phenotypes

Because so few patients have been published, phenotype frequencies below are counts across reported cases, not population percentages, and should be labeled with low confidence.

Phenotype	Type	Suggested HPO term	Notes / source
Impaired intellectual development (moderate–severe, IQ 35–50 in the founder kindred)	Cognitive/behavioral	HP:0002342 (Intellectual disability) or graded HP:0002342 subclasses (mild HP:0001256, moderate HP:0002342-moderate, severe HP:0010864)	Founder family: PMID:21937992
Poor language development/speech delay	Behavioral/developmental	HP:0002465 (Impaired language development) / HP:0000750 (Delayed speech and language development)	PMID:21937992; Wikipedia/OMIM synthesis of MRT43
Delayed fine motor development	Developmental/motor	HP:0010862 (Delayed fine motor development)	Founder kindred
Short stature	Physical/growth	HP:0004322 (Short stature)	Founder kindred and Assoum third patient
Macrocephaly	Physical	HP:0000256 (Macrocephaly)	Two Assoum sisters (PMID:31953988)
Microcephaly	Physical	HP:0000252 (Microcephaly)	Assoum third (older) patient — note this is discordant with macrocephaly in the sisters, underscoring phenotypic heterogeneity across the allelic series
Dysmorphic facial features (variably described)	Physical	HP:0001999 (Abnormal facial shape)	Multiple reports; not a single consistent gestalt
Skeletal anomalies	Physical	HP:0000924 (Abnormality of the skeletal system)	Assoum sisters
Subependymal heterotopic nodules	Neuroimaging finding	HP:0030956 or HP:0002119 (Neuronal loss in the cerebral cortex)/most specific: HP:0030955-type periventricular nodular heterotopia terms	Assoum sisters, brain MRI finding
Congenital absence of right internal carotid artery	Vascular/structural	HP:0100659-type vascular anomaly term (no exact single HPO match found; note as candidate)	Assoum younger sister
Bilateral sensorineural hearing loss	Sensory	HP:0000407 (Sensorineural hearing loss)	Assoum younger sister
Motor clumsiness / fine-motor difficulty, dysmetria, dysdiadochokinesia, mild dysarthria	Neurological/motor	HP:0002015 (dysmetria... — actually cerebellar terms); suggested: HP:0001310 (Dysmetria), HP:0002075 (Dysdiadochokinesia), HP:0001260 (Dysarthria)	Courtland et al. 2021 retrospective clinical analysis of SWIP^P1019R^ patients (PMID:33749590) — mean age 10.4 years at first assessment; no notable symptom exacerbation on follow-up at mean age 21
Skeletal-muscle involvement (myopathic features on biopsy/proteomics)	Laboratory/histopathological	Candidate: HP:0003198 (Myopathy)	Gangfuß et al. 2022 (PMID:34599609) — first report of muscle involvement in WASHC4-related disease; proteomic dysregulation of "neuromuscular axis" proteins in fibroblasts and muscle
Profound developmental disorder	Developmental	HP:0012758 (Neurodevelopmental delay), severe end	Gangfuß sisters

Progression/severity: Within the founder P1019R cohort, longitudinal follow-up (Courtland et al. 2021) found motor/coordination symptoms present from childhood (mean age at first exam 10.4 years) with "no notable symptom exacerbation" by young adulthood (mean age 21) — i.e., in humans the disease currently reads as a static/stable neurodevelopmental disorder with fixed cognitive impairment, though the authors explicitly flag that the corresponding mouse model shows progressive motor decline and neurodegeneration markers with age and caution this may "predict future disease progression" not yet captured by the still-limited human follow-up interval.

Quality of life impact: Not formally measured with instruments (EQ-5D/SF-36/PROMIS) in any published cohort; qualitative reports describe moderate-to-severe functional impairment requiring educational/adaptive support.

4. Genetic/Molecular Information

Causal gene: WASHC4 (KIAA1033; HGNC:29174; NCBI Gene 23325; OMIM *615748), chromosome 12q23.3.

Pathogenic variants identified to date (protein-coding, NM_015555/legacy KIAA1033 numbering as reported): | Variant (protein) | Variant (cDNA, where reported) | Type | Zygosity | Source | |---|---|---|---|---| | p.Pro1019Arg (P1019R) | c.3056C>G, exon 29 | Missense (destabilizing) | Homozygous | Founder Omani family, PMID:21937992; mechanistically studied PMID:33749590 | | p.Gln442 | — | Nonsense/truncating | Compound heterozygous (with Asp1048Gly) | PMID:31953988 | | p.Asp1048Gly | — | Missense | Compound heterozygous (with Gln442) | PMID:31953988 | | p.Lys1079Arg | — | Missense | Compound heterozygous (with His503Arg) | PMID:31953988 | | p.His503Arg | — | Missense | Compound heterozygous (with Lys1079Arg) | PMID:31953988 | | Homozygous variant (specific change not captured in this pass) | — | — | Homozygous | Gangfuß et al. 2022, PMID:34599609 |

Curation note: exact HGVS cDNA numbering for the Gangfuß variant and full ACMG classifications for all variants should be pulled directly from ClinVar/the primary papers before entry into the KB rather than relied upon from this summary.

Variant classification (ACMG/AMP): Not independently verified here against ClinVar; OMIM and the case reports treat P1019R and the Assoum/Gangfuß variants as disease-causing based on segregation plus functional evidence (protein destabilization, reduced WASH-complex incorporation). A dedicated ClinVar/VarSome pull is recommended during curation to obtain current classifications and population allele counts.

Allele frequency: Not independently retrieved from gnomAD in this pass (tool access to gnomAD/ClinVar web endpoints was not completed successfully). Given the gene's apparent essentiality in mice (embryonic lethality of complete knockout — see §15), WASHC4 is expected to show constraint against biallelic loss-of-function in human population databases; this should be confirmed directly against gnomAD gene constraint metrics (pLI/LOEUF) during curation.

Functional consequences: - WASHC4 encodes SWIP, an obligate structural subunit of the pentameric WASH regulatory complex (WASH1/WASHC1, FAM21/WASHC2, WASHC3/CCDC53, WASHC4/SWIP, WASHC5/Strumpellin). - The WASH complex is a nucleation-promoting factor (NPF) that recruits and activates the Arp2/3 complex at endosomal membranes to drive branched actin polymerization, which in turn powers fission of tubular transport carriers during endosomal sorting/recycling (retromer-associated cargo sorting). - The P1019R substitution lies in the region of SWIP thought to mediate binding to Strumpellin (WASHC5). Functionally: mutant SWIP "co-immunoprecipitated significantly less Strumpellin and WASH1 (IP: 54.8% and 41.4% of WT SWIP, respectively)" (PMID:33749590), destabilizing the whole WASH pentamer. Patient-derived cells show reduced levels of KIAA1033/SWIP and other WASH-complex members compared to controls. - Net effect: partial loss-of-function of the WASH complex → impaired endosomal actin dynamics and impaired endosome-to-plasma-membrane / endosome-to-Golgi trafficking, with downstream endo-lysosomal pathway perturbation (see §6).

Modifier genes: None established.

Epigenetic information: Not reported for this disease.

Chromosomal abnormalities: None reported; this is a single-gene, sequence-level variant disorder, not a copy-number/structural disorder.

5. Environmental Information

No environmental toxin, lifestyle, or infectious contributors have been described. This is a purely monogenic recessive disorder.

6. Mechanism / Pathophysiology

Ordered causal chain (synthesized primarily from Courtland et al. 2021, PMID:33749590, the only mechanistic dissection to date; steps marked "inferred" are extrapolated from the mouse model to the human disease and have not been independently confirmed in human brain tissue):

Biallelic WASHC4 variants (e.g., c.3056C>G/p.Pro1019Arg) → produce a SWIP protein with an altered residue in its Strumpellin-binding interface.
This leads to (demonstrated by co-immunoprecipitation) markedly reduced binding of mutant SWIP to Strumpellin (WASHC5) and WASH1 (WASHC1) — quantitatively, mutant SWIP pulled down only ~55% and ~41% of the Strumpellin and WASH1 that wild-type SWIP does.
Reduced complex assembly results in destabilization and reduced steady-state abundance of the entire pentameric WASH regulatory complex in patient cells and in P1019R knock-in mouse brain (decreased Strumpellin and WASH1 protein levels on Western blot).
WASH-complex destabilization leads to loss of Arp2/3-mediated branched actin nucleation at endosomal membranes, impairing the fission of tubular endosomal transport carriers required for normal cargo sorting/recycling.
This produces measurable perturbation of the neuronal endo-lysosomal proteome: quantitative spatial proteomics of mutant mouse brain shows a WASH-associated protein module (M38) significantly decreased in abundance, while a lysosomal protease module (M36, containing cathepsins CTSA, CTSB, CTSS, CTSL) is increased in abundance — consistent with compensatory/consequent lysosomal stress.
In parallel, markers of endoplasmic reticulum stress and unfolded-protein-response activation are increased, and primary neurons show morphologically enlarged early-endosomal (EEA1+) compartments alongside fewer but larger Cathepsin-D+ lysosomal puncta — i.e., a shift toward fewer, larger, dysfunctional endo-lysosomal organelles.
Over time this leads to (in the mouse) accumulation of lipofuscin — electron-dense lysosomal residual-body inclusions visible by transmission electron microscopy — a recognized biomarker of neurodegenerative processes, together with increased cleaved caspase-3 (apoptotic) staining in motor cortex that becomes more pronounced with age (significantly greater at 10 months than at younger ages).
Downstream, this endo-lysosomal/neurodegenerative cellular phenotype is proposed (mechanistic step 8 is an inference bridging cellular pathology to the behavioral phenotype, not directly proven by a single intermediate assay) to produce the two clinical/behavioral phenotype domains documented in the mouse and, correspondingly, in human patients:
Cognitive: a specific deficit in cued fear memory (20–30% reduction in conditioned freezing) in mice, with episodic/working memory relatively spared — broadly paralleling impaired intellectual development in human patients, though the mouse assay is not a direct model of human IQ deficits (cross-species extrapolation, flagged as indirect).
Motor: progressive motor dysfunction — ~50% reduction in rotarod performance, altered adult gait (slower, longer strides, decreased homologous limb coupling) — paralleling the "clumsy" movement, fine-motor difficulty, dysmetria, dysdiadochokinesia, and mild dysarthria retrospectively documented in human SWIP^P1019R^ patients (mean age 10.4 years at exam).
Whether the motor/cognitive phenotype in humans will progress in parallel with the mouse's age-dependent neurodegenerative course is unresolved: follow-up of the original human cohort to a mean age of 21 showed no notable symptom exacerbation, but the authors explicitly note the mouse data "may predict future disease progression" not yet apparent in the still relatively young human cohort — an open question rather than an established human natural history.

Molecular pathway: Endosomal actin cytoskeleton regulation via the WASH complex → Arp2/3 activation (Rho-GTPase-adjacent branched-actin nucleation pathway), intersecting with retromer-mediated endosomal cargo sorting.

Cellular processes involved: Endosomal membrane tubulation/fission, actin polymerization, lysosomal proteolysis (cathepsin pathway), ER stress/unfolded protein response, and (in the mouse cortex) apoptosis (cleaved caspase-3).

Suggested GO terms: GO:0071203 (WASH complex), GO:0034315 (regulation of Arp2/3 complex-mediated actin nucleation), GO:0032456 (endocytic recycling), GO:0007015 (actin filament organization), GO:0006914 (autophagy)/lysosomal proteolysis GO:0006508.

Suggested cell types (CL): CL:0000540 (neuron) — cortical/motor-cortex neurons specifically implicated; primary cortical neuron cultures used experimentally.

Suggested UBERON terms: UBERON:0001384 (motor cortex), UBERON:0000955 (brain) generally; skeletal muscle tissue (UBERON:0001134) for the Gangfuß et al. myopathic phenotype.

Molecular profiling data available: Quantitative spatial (region-resolved) proteomics of mutant vs. wild-type mouse brain (Courtland et al. 2021) is the principal -omics dataset; patient/sister fibroblast and muscle-biopsy proteomics in Gangfuß et al. 2022. No transcriptomic, single-cell, or spatial-transcriptomic human datasets were identified for this disease in this search pass.

7. Anatomical Structures Affected

Organ level: Primary — central nervous system (brain, particularly cortex/motor cortex); secondary — skeletal muscle (Gangfuß et al., myopathic proteomic/histologic changes), inner ear (sensorineural hearing loss in one patient), vasculature (absent internal carotid artery in one patient), skeleton (short stature, skeletal anomalies).
Body systems: Nervous system (primary), musculoskeletal system, auditory system, and vascular system (secondary/variable).
Tissue/cell level: Cortical and motor-cortex neurons; skeletal myofibers; primary neuronal cultures used experimentally show altered early endosome (EEA1+) and lysosomal (Cathepsin-D+) compartments.
Subcellular level (GO Cellular Component): Early endosome, late endosome/lysosome, ER (UPR activation implicated).
Localization: Bilateral/systemic — no clear lateralization reported, aside from the single-patient right-sided carotid anomaly.

8. Temporal Development

Onset: Developmental period — global developmental delay apparent in early childhood; the founder kindred and Assoum patients were characterized from childhood, with the eldest reported patient assessed at age 34 showing a milder residual phenotype (mild ID, short stature, microcephaly).
Onset pattern: Insidious/developmental rather than acute.
Progression: In humans, described to date as a largely static neurodevelopmental disorder through young adulthood (no exacerbation from mean age 10.4 to 21 in the Courtland cohort); the corresponding mouse model shows clear age-dependent progression (worsening gait/rotarod performance, increasing apoptotic markers by 10 months), raising an open question about long-term human natural history.
Disease course pattern: Chronic, lifelong intellectual disability; motor/coordination symptoms present from childhood.
Critical periods: Not formally established; developmental brain windows are presumed relevant given the neurodevelopmental phenotype, but no intervention window has been defined.

9. Inheritance and Population

Inheritance pattern: Autosomal recessive.
Prevalence/incidence: Not established — likely fewer than 15–20 published patients worldwide across 4 kindreds/reports (7 in the founder Omani family, 3 in Assoum et al., 2 in Gangfuß et al., plus scattered smaller mentions). This is an ultra-rare, likely underdiagnosed disorder; no population-based prevalence estimate exists in Orphanet or GBD-type sources as of this search.
Penetrance: Appears fully penetrant among reported homozygotes/compound heterozygotes, though sample size is far too small to formally estimate penetrance.
Expressivity: Variable — the phenotype spans "non-syndromic" ID with short stature (founder family) to syndromic presentations with macrocephaly, dysmorphism, skeletal and vascular anomalies, and hearing loss (Assoum sisters) to myopathic/skeletal-muscle involvement (Gangfuß sisters), and to a milder adult phenotype (Assoum's third, older patient). This variable expressivity is a key open question flagged explicitly by Assoum et al.: "additional description will be needed to refine the clinical phenotype."
Genetic anticipation: Not applicable/not reported (not a repeat-expansion disorder).
Germline mosaicism: Not reported.
Founder effects: The P1019R allele appears to be a founder variant in the reported large consanguineous Omani family; not established as a broader population founder allele.
Consanguinity: A dominant risk factor across all reported kindreds — the founder family and at least one Assoum family are explicitly consanguineous.
Carrier frequency: Not established; would need direct gnomAD query.
Population demographics: Cases reported from Oman (Middle East/Gulf) and from French cohorts (Assoum et al., Dijon, France) and German cohorts (Gangfuß et al.), suggesting no single ethnic restriction, but numbers are too small for meaningful geographic epidemiology.
Sex ratio: Reported cases include both male and female patients (e.g., sister pairs in two of the four kindreds); no skew has been reported, consistent with autosomal (non-sex-linked) inheritance.

10. Diagnostics

Genetic testing (primary diagnostic modality): Diagnosis is genetic/molecular — all reported cases were ascertained via homozygosity mapping plus targeted/exome sequencing (founder family, PMID:21937992) or clinical exome sequencing (Assoum et al., Gangfuß et al.). Given the rarity and phenotypic heterogeneity, exome or genome sequencing (rather than a targeted single-gene test) is the practical diagnostic approach, typically as part of an intellectual-disability/developmental-delay gene panel or trio-exome analysis.
Chromosomal microarray: Would typically be performed as first-tier testing to exclude CNV causes of ID before/alongside sequencing, though not specifically discussed in the WASHC4 literature.
Neuroimaging: Brain MRI identified subependymal heterotopic nodules and carotid artery anomaly in one family (Assoum et al.) — suggesting MRI should be part of the diagnostic work-up when WASHC4-related ID is suspected or confirmed.
Audiology: Sensorineural hearing loss was identified in one patient — supports baseline audiologic screening.
Muscle biopsy/proteomics: Gangfuß et al. used muscle biopsy with proteomic analysis to identify neuromuscular-axis protein dysregulation — a research-level rather than routine clinical diagnostic tool at present.
Differential diagnosis: Other autosomal recessive non-syndromic/syndromic ID genes (there are now 50+ recognized ARID loci from the Najmabadi 2011 study alone), other WASH-complex-related disorders (e.g., WASHC5/Strumpellin-related hereditary spastic paraplegia/Ritscher-Schinzel-like phenotypes, WASHC3-related short-stature/dysmorphism syndrome — PMID:40129681 identified in this search, and CCDC22-related Ritscher-Schinzel-like phenotype, PMID:40448120), and other causes of syndromic ID with macrocephaly or microcephaly, skeletal anomalies, and myopathic features.
Standardized diagnostic criteria: No disease-specific consensus diagnostic criteria have been published; diagnosis rests on identification of biallelic WASHC4 variants in the context of a compatible ID phenotype.
Screening: No newborn or population screening program exists for this ultra-rare condition; carrier screening could theoretically be offered in populations/families with a known WASHC4 founder allele (e.g., via targeted testing in consanguineous Omani kindreds), but this is not a documented public-health practice.

11. Outcome/Prognosis

Survival/mortality: No mortality data reported; this does not appear to be associated with reduced lifespan based on available (very limited) follow-up data, though systematic survival data do not exist.
Morbidity/function: Chronic intellectual disability with variable motor coordination deficits; functional impact is lifelong, and the oldest reported patient (age 34) still had ID (albeit milder), indicating persistence into adulthood.
Complications: Reported additional morbidities in individual patients include sensorineural hearing loss, vascular anomaly (absent internal carotid artery), and skeletal-muscle/myopathic involvement — the clinical significance and management implications of the myopathic finding are newly described and not yet fully characterized.
Recovery potential: No treatment reverses the underlying molecular defect; supportive/developmental intervention is the mainstay (see §12).
Prognostic factors: Genotype–phenotype correlation is not yet established; the milder adult phenotype in Assoum's third patient (compound heterozygous missense/missense) versus the more syndromic pediatric phenotype in the sisters (nonsense/missense) may hint that variant type/residual protein function modulates severity, but this is speculative given the small numbers.
Prognostic biomarkers: None established; lipofuscin accumulation and cathepsin/lysosomal proteome changes are mechanistic/model-organism findings, not validated clinical biomarkers.

12. Treatment

There is no disease-specific or targeted pharmacotherapy for WASHC4-related ARID; management is entirely supportive/symptomatic, consistent with most ultra-rare monogenic ID syndromes.

Supportive care / rehabilitative: Special education and adaptive-skills support; physical therapy for motor/coordination deficits (dysmetria, dysdiadochokinesia, gait abnormality); speech-language therapy for language delay/dysarthria; occupational therapy for fine-motor difficulties. Suggested NCIT terms: NCIT:C15302 (Physical Therapy), NCIT:C159273 (Speech Therapy — if used in your schema), NCIT:C121351 (Occupational Therapy).
Hearing loss management: Audiologic evaluation and hearing-aid/cochlear-implant consideration for the subset of patients with sensorineural hearing loss (NCIT device-pattern term as documented elsewhere in this KB, e.g., NCIT:C157820 Cochlear Implant bound via qualifiers, with NCIT:C15329 Surgical Procedure as the treatment_term, per this repository's established convention).
Genetic counseling: Recommended for families given autosomal recessive inheritance, particularly in consanguineous kindreds. NCIT: NCIT:C15240 (Genetic Counseling).
Vascular anomaly / skeletal anomaly management: Case-by-case surgical/orthopedic evaluation as clinically indicated (no disease-specific surgical protocol established).
Experimental/investigational therapies: None identified — no clinical trials (ClinicalTrials.gov) were found for WASHC4-related ID in this search. The mechanistic work (Courtland et al. 2021) raises endo-lysosomal/autophagy pathway modulation as a conceptual future therapeutic target, but this is speculative and pre-clinical (mouse-model-stage) only, not an active therapeutic program.
Treatment outcomes: Not applicable — no disease-modifying treatment exists to report response rates or adverse events for.

13. Prevention

Primary prevention: Not applicable to a monogenic recessive disorder beyond reproductive genetic counseling.
Secondary prevention: Early identification via genetic testing in at-risk families (especially consanguineous kindreds or those with a known WASHC4 allele) could enable earlier initiation of developmental/educational support, though no formal early-intervention protocol specific to this disease has been published.
Genetic counseling / reproductive options: Carrier testing, prenatal diagnosis, and preimplantation genetic testing are theoretically available once a familial pathogenic variant is identified, standard for autosomal recessive Mendelian disorders, though not specifically documented as implemented for WASHC4 families in the literature reviewed.
Screening programs: None exist at a population level given the disorder's rarity.

14. Other Species / Natural Disease

No naturally occurring WASHC4-associated disease has been reported in non-human species (companion animals, livestock, or wildlife) in the literature surveyed; this appears to be a human-only clinical entity to date, studied comparatively only through engineered mouse models (see §15). WASHC4 orthologs are broadly conserved (the WASH complex is conserved across eukaryotes with an actin cytoskeleton and endosomal trafficking machinery), but no OMIA (Online Mendelian Inheritance in Animals) entry or veterinary case series was identified.

15. Model Organisms

Mouse (Mus musculus) — the only characterized model system for this disease:

Gene: Washc4, MGI:2441787, chromosome 12 (syntenic region).
Complete knockout: Mice homozygous for a Washc4 null/knockout allele show early embryonic phenotypes — decreased embryo size, rudimentary egg cylinder, and failure of normal early development — consistent with embryonic lethality of complete WASH complex loss. This indicates WASHC4/WASH-complex function is essential for early mammalian development, and that human patients (who survive to birth and beyond) necessarily carry hypomorphic/partial-function alleles rather than true nulls.
Patient-variant knock-in model — SWIP^P1019R^ mouse (Courtland et al. 2021, PMID:33749590; eLife 10:e61590): A CRISPR-engineered mouse carrying the exact human WASHC4 c.3056C>G (P1019R) mutation is viable and recapitulates key aspects of the human disease:
Molecular: Destabilized WASH complex (reduced Strumpellin/WASH1 co-IP and abundance), perturbed endo-lysosomal proteome (decreased WASH-module proteins, increased lysosomal cathepsins), ER stress/UPR activation, enlarged early-endosome and lysosome puncta in primary neurons.
Histopathological: Lipofuscin accumulation (electron-dense lysosomal residual bodies) and age-dependent increase in cleaved caspase-3 (apoptotic) staining in motor cortex — neurodegeneration-associated findings not yet directly confirmed in human patient tissue (a model-to-human translational gap).
Behavioral/cognitive: Specific deficit in cued fear memory (20–30% reduction in freezing) with spared episodic/working memory.
Motor: Progressive deficits — ~50% reduction in rotarod performance, altered gait (slower, longer strides, decreased homologous limb coupling) that emerges/worsens with age.
Translational correlation: The authors performed a retrospective clinical re-examination of the original human SWIP^P1019R^ patients and found parallel motor findings (clumsiness, dysmetria, dysdiadochokinesia, mild dysarthria), supporting the mouse model's face validity for the motor domain specifically.
Model limitation (fidelity caveat): The mouse shows clear age-dependent progression of motor deficits and neurodegenerative histopathology, whereas the limited human follow-up data (to mean age 21) show no clear worsening — so the mouse model's progressive/neurodegenerative trajectory is not yet confirmed to translate to the human disease course; this is an explicit open question raised by the study's authors rather than a settled cross-species correlation. The cognitive assay (cued fear conditioning) is also a rodent-specific paradigm and only indirectly models human intellectual disability.
Model resources: Washc4 mouse data are catalogued at MGI (informatics.jax.org/marker/MGI:2441787) and IMPC (mousephenotype.org/data/genes/MGI:2441787), which report on the order of 24 phenotype annotations across 2 alleles in 2 genetic backgrounds (complete knockout plus the P1019R knock-in).
Other model systems: No zebrafish, Drosophila, C. elegans, or iPSC/organoid models specific to WASHC4-related ID were identified in this search (note: one unrelated C. elegans dopamine/ethanol-response paper surfaced in searches but concerns a different WASH-pathway context and is not disease-relevant here).

Summary of Key Ontology Term Suggestions for KB Curation

Gene: hgnc:29174 (WASHC4)
Disease: MONDO:0014354; OMIM:615817
HP terms (representative, to be individually verified against current HPO before binding): HP:0002342 (Intellectual disability), HP:0000750 (Delayed speech and language development), HP:0010862 (Delayed fine motor development), HP:0004322 (Short stature), HP:0000256 (Macrocephaly), HP:0000252 (Microcephaly), HP:0000407 (Sensorineural hearing loss), HP:0001310 (Dysmetria), HP:0002075 (Dysdiadochokinesia), HP:0001260 (Dysarthria), HP:0003198 (Myopathy)
GO terms: GO:0071203 (WASH complex), GO:0034315 (regulation of Arp2/3 complex-mediated actin nucleation), GO:0032456 (endocytic recycling)
CL term: CL:0000540 (neuron)
UBERON terms: UBERON:0001384 (motor cortex), UBERON:0001134 (skeletal muscle tissue)
NCIT treatment terms: NCIT:C15302 (Physical Therapy), NCIT:C121351 (Occupational Therapy), NCIT:C15240 (Genetic Counseling)

Curation Caveats

Several web sources (PubMed abstract pages, OMIM, HPO JAX browser) returned bot-blocked/403/404 responses during this research session; abstracts and structured data above were reconstructed via Europe PMC, GeneCards, MalaCards, and general web search snippets rather than direct primary-source fetches in all cases. Before finalizing evidence snippets for KB entry, re-fetch PMID:21937992, PMID:31953988, PMID:33749590, and PMID:34599609 directly (e.g., via just fetch-reference) to obtain exact quotable abstract text, and independently verify OMIM #615817's clinical synopsis and molecular genetics paragraphs, and ClinVar/gnomAD data for the specific variants listed.
Exact HGVS cDNA-level nomenclature for the Gangfuß et al. 2022 variant was not retrieved in this pass and should be sourced from the primary paper.
HPO term bindings above are suggestions based on phenotype descriptions in secondary/aggregator sources, not verified against the live HPO ontology in this session — this repository's dismech-terms skill/validation pipeline should be run before committing any bindings.
Prevalence/incidence figures could not be located in Orphanet, GBD, or other epidemiological registries — this is very likely because the entity is too rare/recently described to have an assigned prevalence class; record as prevalence_class: NOT_YET_DOCUMENTED if modeled in the KB schema.

Sources: - OMIM #615817 — INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 43; MRT43 - OMIM *615748 — WASH COMPLEX, SUBUNIT 4; WASHC4 - Najmabadi H et al., "Deep sequencing reveals 50 novel genes for recessive cognitive disorders," Nature 2011 — PMID:21937992 - Assoum M et al., "Novel KIAA1033/WASHC4 mutations in three patients with syndromic intellectual disability and a review of the literature," Am J Med Genet A 2020 — PMID:31953988 - Courtland JL et al., "Genetic disruption of WASHC4 drives endo-lysosomal dysfunction and cognitive-movement impairments in mice and humans," eLife 2021 — PMID:33749590 / PMC7984842 - Gangfuß A et al., "Homozygous WASHC4 variant in two sisters causes a syndromic phenotype defined by dysmorphisms, intellectual disability, profound developmental disorder, and skeletal muscle involvement," J Pathol 2022 — PMID:34599609 - WASHC4 Gene — GeneCards - WASHC4 — NCBI Gene 23325 - Washc4 — MGI:2441787 Mouse Gene Detail - Washc4 — IMPC (Mouse Phenotype) - MalaCards — Intellectual Developmental Disorder, Autosomal Recessive 43 - Orphanet — WASHC4 gene page - MONDO:0014354 — EBI OLS

Reference Validation

Checked with linkml-reference-validator 0.2.1.

Outcome	Count
References checked	7
Resolved	7
Unresolved (possible confabulation)	0
Unverifiable	0
Quoted claims checked	1
Quoted claims found in source	1
Quoted claims not found in source	0
References weighed for topical relevance	7
On topic	6
Off topic	0

All extracted references resolved successfully.

Term Validation

Checked with linkml-term-validator 0.4.5, through the ols: adapter.

Outcome	Count
Terms checked	43
Resolved	39
Unresolved (possible confabulation)	0
Obsolete	0
Unverifiable	4
Terms whose name was checked	27
Terms named correctly	24
Terms named as a different term	1
Terms whose name is worth a second look	2

Terms the report names something else

These identifiers resolve, so nothing about them looks wrong, and the ontology calls them something unrelated to what the report calls them. That usually means the identifier is not the one the sentence needs:

MONDO:0014354 (3 mentions) - the report calls it "MONDO", "EBI OLS"; MONDO calls it intellectual disability, autosomal recessive 43

Terms whose name is worth a second look

The report's name for these is recognisably related to the term's own name without being one of them. A loose paraphrase reads the same way as a citation of the wrong sibling term - and so does a related synonym, which the ontology records precisely because it names something adjacent rather than the same thing - so these are listed rather than judged:

HP:0002342 (4 mentions) - the report calls it "Intellectual disability"; HP calls it Moderate intellectual disability
HP:0002075 (2 mentions) - the report calls it "Dysdiadochokinesia"; HP calls it Dysdiadochokinesis, and lists "Dysdiadochokinesia" among its other names

Terms named inconsistently

The report gives these identifiers more than one name of its own:

MONDO:0014354 - called "MONDO", "EBI OLS"

Prefixes with no resolver

Terms carrying these prefixes were not checked either way, because no configured ontology covers them. An unrecognised prefix may name an ontology this run could not reach as easily as one that does not exist, so nothing here is evidence of fabrication: ORPHA, MGI, OMIM.

Ask OpenScientist

OpenScientist Report

Classifications

Mappings

Inheritance

Discussions and Knowledge Gaps

Pathophysiology

Pathograph

Phenotypes

Genetic Associations

Medical Actions

Diagnosis

Prevalence

Differential Diagnoses

Experimental Models

Animal Models

Source YAML

References & Deep Research

References

Deep Research

1. Disease Information

2. Etiology

3. Phenotypes

4. Genetic/Molecular Information

5. Environmental Information

6. Mechanism / Pathophysiology

7. Anatomical Structures Affected

8. Temporal Development

9. Inheritance and Population

10. Diagnostics

11. Outcome/Prognosis

12. Treatment

13. Prevention

14. Other Species / Natural Disease

15. Model Organisms

Summary of Key Ontology Term Suggestions for KB Curation

Curation Caveats

Reference Validation

Term Validation

Terms the report names something else

Terms whose name is worth a second look

Terms named inconsistently

Prefixes with no resolver